Search for protein-protein interactions underlying the cis-preferential replication of turnip yellow mosaic virus by Dreher, Theo W. et al.
AN ABSTRACT OF THE THESIS OF
S. Ellen Wallace for the degree of Master of Science in Microbiology
presented on January 28, 1997. Title: Search for Protein-Protein
Interactions Underlying the Cis-Preferential Replication of Turnip
Yellow Mosaic Virus.
Abstract approved:
Theo W. Dreher
Coreplication experiments have revealed that replication of
turnip yellow mosaic virus (TYMV) RNA in turnip protoplasts is cis-
preferential. Genomes encoding mutant p141 or p66, proteins
essential for virus replication, were inefficiently rescued by a
helper genome. One model for the cis-preferential replication of
TYMV is that p66 and p141 form a complex that associates with the
RNA from which they are translated, limiting their availability in
trans. Three types of experiments were used in this study in an
attempt to obtain physical evidence for the hypothetical interaction
between p66 and p141. Immunoprecipitations from in vitro
translation reactions using antiserum that recognizes p66 (and its
progenitor, p206) coprecipitate p141, indicating that the proteins
form a complex in vitro. The results of coimmunoprecipitations of
translation products with in-frame deletions did not lead to
definitive information about interaction domains. p66 and the
helicase domain of p141 do not detectably interact in the yeast two-
hybrid system or in GST fusion interaction assays. Problems with
the expression of full length p141 fusions make conclusions about
the interaction of other p141 domains with p66 not possible at this
time. Since the helicase domain of p141 does not appear to interact
with p66, future experiments will focus on obtaining expression of
smaller domains of p141, outside the helicase domain, and
determining if they interact with p66. Variations to the model that
do not necessitate the direct interaction between p66 and p141 are
also considered.
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1. General Introduction
1.1Classification of Turnip Yellow Mosaic Virus
The genome of turnip yellow mosaic virus (TYMV) consists of
a 6.3 kb positive sense RNA, and is encapsidated by viral-encoded
capsid proteins to form a 29 nm icosahedron. TYMV is the type
member of the tymoviruses, which are included in the Sindbis-like,
or alphavirus-like, supergroup (Morch et al., 1988; Goldbach and
Wel link, 1988). Based on similarity of sequences and genome
organization, Koonin and Dolja (1993) placed plus strand RNA
viruses into three supergroups. Supergroup I contains the picorna-
like viruses, supergroup II includes RNA phages and flaviviruses,
and supergroup III contains the Sindbis-like viruses. All members
of supergroup III produce a subgenomic mRNA, which along with
the genomic RNA, has a 5' cap. Polymerase- and helicase-like
domains are generally present, as well as a methyltransferase
domain that appears to be unique to supergroup III, althoughsome
of the smaller members lack this domain (Rozanov et aL, 1992). In
TYMV and other monopartite members of supergroup III, the order
of the conserved domains (N-terminal to C-terminal) is consistently
methyltransferase, helicase, polymerase.2
1.2Genome Organization
The three open reading frames encoded by TYMC (Corvallis
strain of TYMV) are diagramed in Figure 1.1. ORF-69 initiates at
nucleotide 88 and terminates at nucleotide 1971 (Morch et al.,
1988; Dreher and Bransom, 1992) and encodes a 69 -kDa protein
involved in viral cell-to-cell movement (Bozarth et al., 1992). ORF-
206 encodes a 206-kDa protein with methyltransferase-, helicase-
and polymerase-like domains (Morch et al., 1988; Gorbalenya and
Koonin, 1989; Rozanov et al., 1992). The protein also contains a
protease domain that functions in cis to cleave the 206-kDa protein
into 141-kDa and 66 -kDa proteins (Bransom and Dreher, 1994;
Bransom et al., 1996). ORF-206 initiates at nucleotide 95, terminates
at nucleotide 5626 and is in the +1 frame in relation to ORF-69. CP-
ORF is in the same reading frame as ORF-69, and encodes a 20-kDa
capsid protein expressed from a subgenomic RNA. The CP-ORF
extends from nucleotide 5644 to nucleotide 6210 (Morch et al.,
1988).
Only 3% of the TYMV genome is non-coding. The 5'
untranslated region (UTR) has not been extensively studied, but it
does have a m7GpppG cap, as does the the 5' end of the subgenomic
RNA (Briand et al., 1978). The 3' UTR contains a tRNA-like structure
that can be aminoacylated with valine in vitro (Pinck et aL, 1970;
Dreher et aL, 1988) and in vivo (Joshi et al., 1982).3
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Figure 1.1. Diagram of TYMC. (A) The cDNA insert of pTYMC.
Infectious transcripts can be made by using T7 RNA polymerase to
transcribe Hindi I I linearized DNA. (B) Diagram of the ORF-206
product. The protein domains with conserved motifs or known
function, the core amino acids of the helicase- and polymerase-like
domains (GCGKT and GDD respectively), and the protease cleavage
site between amino acids 1259 and 1260 are shown.
1.3Conserved Protein Domains and their Functions
1.3.1Movement proteins
As was mentioned above, some of the proteins encoded by
TYMV share sequence homology with other plant and animal RNA
viruses. Movement proteins, like the 69-kDa protein of TYMV, are
unique to plant viruses. Although p69 is not necessary for TYMV
replication in protoplasts, it is necessary for the spread of infection
in whole plants (Bozarth et al., 1992). p69 has a high pI (12.1),
suggestive of nucleic acid binding properties. The 69-kDa movement4
protein is phosphorylated when expressed in insect cells (Seron et
aL, 1996) and migrates slower than expected in SDS-PAGE.
The 30-kDa protein of tobacco mosaic tobamovirus (TMV), is a
well studied viral movement protein. The phosphorylated protein is
a single stranded nucleic acid binding protein that is able to modify
plasmodesmata, increasing the molecular exclusion limit from 3.0
nm to 6-12 nm (reviewed in Deom et al., 1992). It is postulated that
p30 coats and unfolds TMV RNA, and facilitates cell to cell
movement through the plasmodesmata (Citovsky et aL, 1990). RNA
binding has been observed by the 26-kDa movement protein of
foxtail mosaic potexvirus (Rouleau et al., 1994) and by the gene I
product of cauliflower mosaic caulimovirus (Citovsky et al., 1991).
1.3.2Capping domains
The amino terminal region of p206/p141 of TYMV contains a
methyltransferase-like domain. This domain is conserved and
specific to members of the Sindbis-like supergroup, and is thought
to be responsible for the methylated 5' cap structure found on the
genomes of these viruses. In contrast, picorna-like viruses have a
VPg protein associated with their 5' genome ends (Rozanov et al.,
1992; Goldbach and Wel link, 1988).
The methyltransferase domain consists of 5 motifs and
contains four strictly conserved amino acids: H in motif I, NXXR in
motif II and Y in motif IV (Rozanov et al., 1992). A
methytransferase activity was detected by methylation of
guanylylimido-diphosphate by the nsP1 protein of Sindbis virus (Mi
and Stollar, 1991). It was determined that changing any of the four
conserved methyltransferase amino acids to A resulted in a protein
with no methyltransferase activity and an RNA that was not
infectious (Wang et al., 1996). The methyltransferase domain of
TYMV is required for replication (Weiland and Dreher, 1993), but it
has not been extensively studied.5
Guanylyltransferase activity has been detected in the nsP1
proteins of both Semliki Forest virus and Sindbis virus. This activity
is likely responsible for the addition of GMP to the 5' end of the
genome, creating a cap 0 structure (m7GpppG). It was found that
this reaction was dependent on the presence of S-
adenosylmethionine (Ado Met), indicating that the methyl group is
added to GTP before GMP is covalently added to the 5' end of the
genome (Ahola and Kaariainen, 1995). The mRNA capping
mechanism found in most mammalian and viral systems involves
first the addition of GMP followed by its methylation. A GTP binding
activity has been detected in tobacco mosaic virus, and unlike that
of Sindbis virus, it was not dependent on the presence of Ado Met
(Dunigan and Zaitlin, 1990). Guanylyltransferase activity has not
been studied in association with TYMV, but it is likely that the
activity is viral-encoded since viral replication occurs in the
cytoplasm.
1.3.3Protease domains
Proteolytic processing of viral-encoded proteins is a common
feature in both plant and animal viruses (Dougherty and Semler,
1993). The proteases responsible for the processing are typically
virally encoded. The protease domain of p206/p141 is responsible
for the specific cleavage of p206 between A1259 and T1260, to
form the N-terminal product, p141 and the C-terminal product, p66
(Chapter 2; Bransom et al., 1996; Kadare et al., 1995). Cleavage of
p206 is essential for viral replication; viruses with mutations that
inactivate the protease or that alter the cleavage site cannot
replicate in protoplasts. In vitro, proteolysis occurs in cis,as is
indicated by the lack of a dilution effect; increasing the reaction
volume did not result in a measurable decrease in proteolysis
(Bransom et al., 1994). It was found that cotranslations in rabbit
reticulocytes of a TYMV RNA encoding a defective cleavage site, and6
of a TYMV RNA encoding a defective protease, did not result in any
proteolysis products, indicating that the protease does not function
in trans. However, it is possible in this system that the functional
protease was bound to the defective cleavage site and unavailable
to work in trans. C783 and H869 were found to be essential
residues and help classify the TYMV protease as a papain-like
protease (Bransom et al., 1994).
1.3.4Helicase domains
NTP-binding motifs, as part of helicase domains, are common
among viruses. Negative strand RNA viruses and retroid viruses
seem to be the only groups that consistently lack this domain
(Gorbalenya and Koonin, 1989). Helicase activity has been detected
in the cytoplasmic inclusion (CI) proteins of plum pox potyvirus
(Lain et al., 1990), and tomarillo mosaic potyvirus (Eagles et aL,
1994). In an ATP-dependent manner, these proteins were able to
separate the strands of circa 20 base pair duplex RNA molecules
with 3' and 5' overhangs
Properties consistent with helicase activity in TYMV have
recently been described for amino acids 916 to 1259 of p206/p141.
This domain was expressed in E. coil and was found to have ATPase,
GTPase and sequence-independent RNA binding activities. The
ATPase and GTPase activities were stimulated two-fold by the
addition of RNA fragments (Kadare et al., 1996). Changing the
conserved nucleotide binding motif GxGKT to GxGST had been
previously shown to prevent replication of TYMV RNA in
protoplasts (Weiland and Dreher, 1993). The same alteration has
now been shown to decrease ATPase and GTPase activity to 15-20%
of wild type (Kadare et al., 1996). In TYMV, the helicase domain
could be responsible for unwinding the 3' tRNA-like structure to
allow negative strand synthesis, and for separating double-stranded
replication intermediates.7
1.3.5RNA-dependent RNA polymerases
RNA-dependentRNApolymerases are essential for the
replication of positive strandedRNAviruses. The conserved
sequence motif characteristic of these polymerases, GDD (Argos et
al., 1988), is found in p206/p66, and mutations in this domain
prevent viral replication (Weiland and Dreher, 1993). A number of
viral and host proteins has been found to be necessary for the
function of the polymerases of other viruses, and will be discussed
later.
1.3.6Capsid protein
As stated earlier, the 20 -kDa capsid protein is expressed from
a subgenomicRNA.The assembled capsid consists of 180 subunits
with T=3 symmetry (Matthews, 1991). It is thought that the loss of
5-9 capsid subunits creates a small hole that allows the release of
theRNAand the initiation of infection (Adrian et aL, 1992). It has
been observed that deletions of theRNAthat encodes the coat
protein prevent systemic symptoms in turnip plants. The coat
protein is therefore important in the establishment of a systemic
infection, perhaps by facilitating long distance viral movement
(Weiland and Dreher, 1993; Bransom et al., 1995).
1.4 Noncoding Regions and other Cis Elements
The 5' untranslated region(UTR)of TYMV does not share
sequence homology with TMV, brome mosaic bromovirus (BMV), or
alfalfa mosaic virus (A1MV) (Briand et al., 1978). In TMV, the 5'UTR
contains a so-calledsequence that enhances translation. This8
sequence works in conjunction with a sequence just 5' of the 3' TLS
of TMV, called the upstream pseudoknot domain (UPD). These
sequences are recognized by proteins in wheat germ and carrot
extracts, which presumably facilitates translation (Leathers et al.,
1993). TYMV does not contain an Q-like sequence, but it does
contain a putative pseudoknot just 5' of the TLS. Even with the
pseudoknot present, the 3' UTR of TYMV was not able to
significantly increase the expression of a reporter gene (Gallie and
Kobayashi, 1994). Another tymovirus, wild cucumber mosaic virus,
has two pseudoknot structures just upstream of the TLS that closely
resemble the UPD of TMV (Hellendoorn et al., 1996).
The TYMV pseudoknot mentioned above may also be involved
in virus replication. It was found that a mutation that would
destabilize the pseudoknot structure (U- 96 =G), resulted in a virus
that replicated poorly and could not cause systemic infection in
plants. Viruses that had regained their ability to spread
systemically contained reversions or a second site suppressor
mutation that restored the pseudoknot structure (Tsai and Dreher,
1992).
tRNA like structures (TLS) are found on the 3' ends of many
plant RNA viruses and most can be aminoacylated. The TLS of
TYMV can be charged with valine, and mutational analysis of the
anticodon loop indicated that the middle nucleotide of the anticodon
is the most important factor for efficient charging (Dreher et al.,
1992). Identity element changes from valine to methionine result in
a TLS that aminoacylates specifically and efficiently with
methionine, and an RNA that is infectious (Dreher et al., 1996).
The tymobox is a highly conserved sequence found in all
tymoviruses. Although it is found in coding regions, the nucleotide
sequence is conserved, not just the amino acids they encode (Ding et
al., 1990). Subgenomic RNA synthesis is initiated on full length
minus-strand template (Gargouri et al., 1989) in a similar manner
as with BMV and A1MV. The tymobox is postulated to be involved
in the recognition or binding of the replicase and an initiation box is9
thought to dictate the subgenomic RNA transcription start site (Ding
et al., 1990).
The tymobox is an example of how cis elements are not
always limited to noncoding regions of the genome. There may be
cis elements in TYMV RNA that have not been identified or
characterized, and this needs to be considered when designing and
analyzing mutants. Deletions, insertions and point mutations in the
coding region of replication proteins may also interfere with RNA
secondary structure and result in a defective template. In the RNA
bacteriophage Qp, cis elements (RNA elements required for
replication) have been found in the replicase coding region (Mills et
al., 1990). Plasmid-encoded Q13 replicase proteins were provided in
trans, and the ability of mutant RNAs to be replicated and produce
virus particles was measured. Many deletions and insertions in the
RNA, some of which were in the replicase coding region, resulted in
low or no virus production. Similar experiments with the Qffi
readthrough region, which adds a 200 amino acid extension to the
capsid protein, have led to the conclusion that stable secondary RNA
structure in this region is required for viral propagation (Arora et
al., 1996).
1.5Replication Complexes
No replication complexes induced by eukaryotic positive-
strand RNA viruses have been characterized sufficiently to
determine subunit composition. However, the viral replication
complexes are thought to be composed of both viral and host
proteins; they are associated with membranes and RNA templates.
In the case of poliovirus, electron microscopy and
immunocytochemistry have been used to deduce how the
replication complexes are formed, and how they are associated with
membranes. It is proposed that soon after the P2 replication
proteins are synthesized, they associate with rough endoplasmic10
reticulum (rER) membranes. The 2BC protein is thought to induce
the formation of smooth vesicles, which eventually detach from the
rER (Bienz et aL, 1987). The 2C protein or a 2C containing precursor,
facilitates the attachment of the viral RNA to the membrane and
directs proper replication complex assembly (Bienz et al., 1990).
Plant viral replication complexes are also associated with
membranes. Viral RNA synthesis for TYMV has been shown tooccur
at invaginations in the chloroplast membrane (Gamier et al., 1986).
The viral proteins associated with the replication complex of
TYMV are probably p206 and/or its cleavage products p141 and
p66. For BMV, proteins la and 2a are known to be part of the
replication complex and have been shown to interact directly with
each other both in vitro (Kao et a1.,1992) and in the yeast two-
hybrid system (O'Reilly et al., 1995).
Proteins la and 2a of BMV are expressed from separate RNAs
(RNA1 and RNA2) and have helicase- and polymerase-like domains,
respectively. In a specially designed BMV replication system in
yeast, assembly of functional replication complexes containing
proteins la and 2a was dependent on the presence of RNA3. The
role or RNA3 is unclear, but it appears to be involved in either
replication complex assembly, activity or stability (Quadt et al.,
1995). Since RNA3 is not required for BMV replication in
protoplasts, it is thought that RNA1 and RNA2 can also facilitate
replication complex formation.
There is to date relatively little informationon host proteins
associated with viral replication complexes. In BMV, a replication
complex-associated barley protein is immunologically cross-reactive
with the p41 subunit of eIF-3 from wheat germ. Itwas found that
adding eIF-3 to the replication complex stimulated negative-strand
RNA synthesis (Quadt et al., 1993). The replication complex of the
Q3 bacteriophage contains the ribosomal protein S1 and the
elongation factors Tu and Ts (Blumenthal et al., 1979). HF-I isa heat
stable host protein involved in minus-strand RNA synthesis of Q0,
but of unknown function in E. coli (Kajitani and Ishihama, 1991). It11
is interesting that translation factors seem to play a role in the
replication complexes of both these viruses.
It has been proposed that different forms of replication
complexes may be required for negative-strand versus positive-
strand synthesis. In Sindbis virus, the replication proteins P1-4 are
translated as a single polypeptide. More P123 is synthesized than
P1234, which is made by readthrough of a termination codon.
Cleavage of P123 by the protease domain of P2 occurs in trans and
results in the cleavage products P1, P2, and P3, but the cleavage
site between P3 and P4 can be cleaved in cis and is preferred This
preferential cleavage results in the initial accumulation of P123 and
P4. P4 contains the polymerase-like domain and is involved in both
positive and negative-strand synthesis. P123 is associated with the
complex responsible for negative strand synthesis but this complex
initiates positive strand synthesis inefficiently. Cleavage of P123 to
produce P1, P2 and P3, results in a replicase complex with a
preference for positive strand synthesis (Lemm et aL, 1994).
Recently, a replicase preparation from TYMV has been
characterized. This replicase preparation can copy TYMV, TMV and
BMV RNAs to relative levels of 100, 18 and 6%, respectively, but it
does not copy poly U, poly A or alfalfa mosaic virus (A1MV) RNA.
The viral and host protein components of this replication complex
have not yet been identified (Ravindra Singh, personal
communication).
1.6 Cis-Preferential Action
Cis-preferential proteins are those that work predominantly
in cis. They are usually discovered when complementation
experiments show that the proteins do not function, or function
poorly, in trans. Cis-preferential action is a common method to
restrict transposition of bacterial transposons, as transposases
generally function much more efficiently in cis than they do in12
trans. There are a number of mechanisms that explain the cis-
preferential action of transposases, some of which will be discussed
below.
A model for the cis-action of the transposase (Tnp) of Tn5 is
based on the formation of nonfunctional multimers. Tnp is known to
dimerize but this form of Tnp is unable to bind DNA. It is thought
that one monomer of Tnp binds one end of the Tn5 sequence and
another Tnp monomer binds the other end. The two Tnp monomers
are thought to then form a productive dimer that initiates
transposition. This reaction occurs in trans infrequently because
Tnp is likely to form a nonproductive multimer with another Tnp
(or inhibitor) molecule before it reaches a distal Tn5 sequence
(Weinreich et al., 1994).
The Tnp of the Tn/ 0 transposon also functions poorly in trans.
The cis-preferential action of this Tnp is thought to be due to either
slow transcript release or poor mRNA stability; it was found that
changes in the mode of transposase gene expression at steps
subsequent to transcription initiation could affect the degree of its
cis action (Jain and Kleckner, 1993). In the case of Tn 903, the lack
of trans action by the transposase seems to be due to the protein's
instability. Using a lon deficient strain of E. coli resulted in trans-
action of the transposase (Derbyshire et al., 1990). Inefficient
translation initiation also appears to limit the levels of transposase
produced by Tn 903 (Derbyshire and Grindley, 1996).
1.7 Cis-Preferential Replication
As with the bacterial transposons, some viruses also encode
proteins that exhibit cis-preferential action. Often they are non-
capsid proteins involved in replication, and show a preference for
the template from which they were synthesized. In these cases
where translation and replication are coupled, replication is termed
cis-preferential.13
Since RNA polymerases have relatively high error rates, it is
to the advantage of the RNA virus to have some mechanism to
prevent the unnecessary replication of defective RNAs. It was noted
that defective interfering (DI) RNAs in polioviruses were very rare,
and the ones that did occur still produced functional replication
proteins. Deletions and insertions were found only in the structural
genes and they all maintained the reading frame of the replication
protein genes. In vitro-constructed poliovirus DI genomes were
active replicons only if the insertions maintained the reading frame
(Hagino-Yamagishi and Nomoto, 1989). On further investigation, it
was determined that a number of poliovirus non-capsid proteins
cannot be provided in trans, including 2A (Novak and Kirkegaard,
1994), 2B (Johnson and Sarnow, 1991), 3A and 3B (Giachetti et al.,
1992).
Clover yellow mosaic potexvirus (CYMV), beet necrotic yellow
vein virus (BNYVV) and alfalfa mosaic virus (A1MV) are plant
viruses that exhibit cis-action that affect replication. CYMV is the
only potexvirus that has had associated defective RNAs identified.
All of the naturally occurring defective RNAs examined maintained
the reading frame of both ORF1 (encodes the putative polymerase)
and ORF5 (encodes the coat protein). It was suggested that
translation of these two reading frames is required to either
facilitate replication of the RNA or to ensure its encapsidation
(White et al., 1992). The cysteine-rich p14 of BNYVV is involved in
cell-to-cell movement of the virus, and is required in cis for the
replication of RNA2 (Hehn et al., 1995). Complementation
experiments were used to determine that the replication of RNAs 1
and 2 of A1MV is coupled to the translation of the encoded proteins
(van Rossum et al., 1996).
Complementation experiments with TYMV revealed that its
replication is also cis-preferential (Weiland and Dreher, 1993).
Replication was detected in turnip protoplasts by Northern analysis.
The constructs used and the relative accumulation levels of viral
RNA in various complementation experiments are shown in Figure
1.2 (adapted from Weiland and Dreher, 1993). The helper genome,14
ACP, has a deletion in the CP-ORF and its replication, as determined
by the accumulation of positive-sense genomic RNA, is only 10% of
that of wild type transcripts. This is thought to be due to the high
degradation rate of unencapsidated RNA, not to lower replication
rates, as negative-sense RNA levels were similar to that of wild
type. The possibility exists, however, that the coat protein has a role
in the stimulation of positive strand synthesis. The helper genome
poorly complemented RNAs with in-frame deletions or substitutions
in ORF-206 (Fig. 1.2). In addition, only a low level of
complementation was observed in experiments with inocula
consisting of a genome (GCGST) containing a substitution in the
conserved helicase motif and a genome (RDD) with a substitution in
the conserved polymerase motif. By contrast, accumulation levels of
49% of wild type resulted from complementation experiments
between a constructs with a large deletion in the p66 coding region
(ASP -G) and the GCGST genome, indicating that cis-preference can
be overcome (Weiland and Dreher, 1993).
Some of the mutant genomes have deletions that affect more
than just protein size and conformation. A4085 -6062, which has
most of the p66 and coat protein coding regions deleted, also has
the cis-acting tymobox and the subgenomic initiation region deleted.
This deletion prevents subgenomic RNA synthesis, so coat protein
levels will be low, and the RNA more readily degraded, possibly
explaining the low levels of positive-sense RNA accumulation when
inoculated together with the GCGST genome (Weiland and Dreher,
1993). This deletion may also remove cis-elements important for
the replication of genomic RNA.Helper genome
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Figure 1.2. Diagram of ORF-206 and CP-ORF for the mutant
genomes studied by Weiland and Dreher (1993). Deleted sequences
are represented by solid bars, dotted bars represent out of frame
sequences prior to stop codons (frame-shift mutants), and black
circles represent point mutations that change the amino acids of the
conserved helicase and polymerase motifs. The names of genomes
used in common coinoculation experiments (ACP, GCGST and ASP-G)
are in bold and are numbered 1-3. The table to the right of the
genome maps shows the accumulation of genomic RNA, relative to
wild-type levels, in coreplication experiments with genomes 1-3.
The ASP-G genome was refered to as TYMC-A4085-5406 by Weiland
and Dreher (1993). This genome was sequenced and it was
determined that the nucleotides joined were 4086 and 5422, as
reflected for ASP-G in this figure.A
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Figure 1.3. Model proposed by Weiland and Dreher (1993)
that explains the cis-preferential replication of TYMV. Three
inoculum combinations and their relative replication compared to
wild type are given. The proposed interactions between p141, p66
and the template RNA are indicated. In (A), wild type, active
replication complexes are formed that are strongly associated with
the template. The complexes formed in (B) are inactive but still
strongly associated with the template. Active complex formation in
(C) is postulated to be due to the availability of wild type p66
provided in trans, translated from the GCGST genome, and the
assembly of active replication complexes on the ASP-G template.
The large deletion in the p66 coding region of the ASP-G genome
prevents the interaction between the encoded p66 and p141, so
that wild type p66 provided in trans can be incorporated into active
replication complexes. p141 must likewise be provided in trans.17
Genomes e3278-3283 and e4085-4090 bothcause
frameshifts that prevent the expression of allor most of p66,
respectively. These frameshifts could affect the suitabilityof
mutant genomes as replication templates by decreasingRNA
stability. Also, since these frameshiftscause early termination of
translation, replication can be affected if translationof these regions
is required to provide a functional template.
A number of mechanismscan explain the cis-preferential
replication of RNA viruses (discussed in Novakand Kirkegaard,
1994). One possibility is that only newly synthesizedproteins are
functional and able to associate with the template.Tight regulation
of translation could assure that only limitedamounts of replication
proteins are made, and they quickly becomeassociated with the
template and form replication complexes.Active translation could
be required so that ribosomes couldremove or induce RNA
secondary structure in the templateor deliver host proteins needed
in replication. It is also possible that proteindiffusion is somehow
restricted, either by a membraneor by the protein's association into
a complex with other proteins.
A model was proposed that explained thecis-preferential
replication of TYMV basedon a theoretical interaction between
p141 and p66. The finding in TYMV thatgenomes with deletions in
the p66 coding region could be complementedby a helper virus, led
to the hypothesis that the deletions might correspondto loss of an
interaction domain. If the interaction of p66was with p141,
analogous to the interaction identified betweenthe helicase and
polymerase-like proteins of BMV (Kaoet al., 1992), the replication
proteins could be sequestered and unavailablein trans. The p141
and p66 proteins were postulatedto be channeled to the template,
possibly to bind the negative-strandpromoter, and assemble into
replication complexes (Weiland and Dreher,1993). Deletion of an
interaction domain in one of the interactingproteins could disrupt
the protein-protein interaction, allowing theproteins to diffuse
from the template, and for complementationto occur. This model,
diagramed in Figure 1.3, explains the cis-preferentialreplication18
data for TYMV; note that this model was suggested in the absence of
evidence for or against a direct protein-protein interaction between
p141 and p66. The purpose of this study was to determine if an
interaction between the two proteins does indeed occur.
1.8Well Characterized Protein-Protein Interaction
Domains
A few proteins involved in protein-protein interactions have
been well studied and characterized. The interaction between two
Gcn4 (a yeast regulatory protein) molecules is an example of a
leucine zipper. This type of interaction domain is found ina helices
where every seventh amino acid is a leucine. The leucine side
chains can project into an a helix of another protein with a similar
cyclical arrangement of leucines and a stable coiled-coil is formed
(O'Sheaet al.,1991).
The SH2 domain of the Src protein, a tyrosine kinase, has been
well studied and has been crystallized in both free and complexed
forms. Whereas the leucine zipper motif can comprise a relatively
large interaction domain, the SH2 domain is restricted to an
interaction region of 5 or 6 residues. The domain consists of
anitiparallel sheets surrounded by two a-helices and has been
likened to a two-holed socket formed by hydrophobic pockets. The
interacting peptide contains phosphotyrosine and has been likened
to a two-pronged plug (Waksmanet al.,1993).
The SH3 domain, also of the Src protein, is composed of
antiparallel sheets and a C-terminal 310 helix. The domain contains
a hydrophobic groove, lined with the side chains of aromatic amino
acids (Yuet al.,1992) that can interact specifically with proline-rich
peptides. Pro line-rich peptides that form left-handed type II
polyproline helices fit into the groove of the SH3 domain (Yuet al.,
1994).19
1.9Methods to Detect Protein-Protein Interactions
There are numerous methods used to detect protein-protein
interactions. Each method has its benefits, obstacles, and drawbacks.
With in vitro techniques, some interactions that are detected are not
necessarily biologically important, and could be just an artifact of
the method. For this reason, it is important to obtain confirmation
from a number of detection methods, and to verify that the two
proteins can occur in the same part of a cell at the same time.
In this study, three techniques were used:
coimmunoprecipitations, yeast two-hybrid studies, and glutathione
S-transferase (GST) fusion interaction assays. Immunoprecipitations
in nondenaturing conditions are a common way of detecting protein
complexes. If a protein coprecipitates with the immunoprecipitation
of another protein, the two proteins likely interact, either directly
or indirectly. Immunoprecipitations can be used in in vivo
experiments with cell lysates or with in vitro translated proteins.
An advantages of in vivo experiments include that the protein
complexes are pre-assembled, and as long as cell lysis does not
disrupt these complexes, they should be in their native state during
the immunoprecipitations (Phizicky and Fields, 1995). Sometimes in
vivo experiments are difficult or not possible due to low
concentrations of the proteins of interest.
Immunoprecipitations of in vitro translated proteins are also
commonly performed and they were used in this study. In both in
vivo and in vitro immunoprecipitations, it is important to use well
characterized antisera. The antibodies must be specific for the
proteins they were made against, and must not cross react with the
coprecipitated proteins. Pre-immune sera should be used to assure
that other antibodies in the sera do not recognize the proteins, and
that the proteins do not nonspecifically adhere to the beads or
Protein A. In in vivo and in vitro immunoprecipitations,
coprecipitating proteins do not necessarily indicate a direct protein-20
protein interaction, as the interaction could be mediated by another
protein (Phizicky and Fields, 1995).
The yeast two-hybrid system developed by Fields and Song
(1989), has become a very popular method to detect protein-
protein interactions. In this system, hybrid proteins are made with
the proteins of interest and either the yeast Gal4 DNA binding
domain or the Ga14 activation domain. If the two proteins of interest
interact, then transcription of a reporter gene is activated. This
method has become popular because it is an in vivo genetic system
that allows for library screening using the bait protein fused to the
Ga14 DNA binding domain. A similar system that replaces the Ga14
DNA binding domain with the E. coil LexA protein is also commonly
used.
False positives can occur with the yeast two-hybrid system if
one protein of interest activates transcription on its own. False
negatives can also occur for reasons including low fusion expression,
poor fusion stability, improper protein folding that makes the
interaction domain inaccessible, and failure of the fusion to locate to
the nucleus. Designing clones that express small domains can avoid
some of these problems (Bartel et al., 1993).
GST fusion interaction assays involve the construction of GST
fusions with the proteins of interest using a pGEX vector or
derivative. This system uses the protein purification system
developed by Smith and Johnson (1988), where GST fusion proteins
produced in E. coli can be purified in nondenaturing conditions
taking advantage of the affinity of GST for glutathione. GST fusion
interaction experiments use the partially purified GST fusion
proteins bound to glutathione-Sepharose or agarose, and add a test
protein, either in a cell lysate or from an in vitro translation. If the
two proteins interact, the test protein will be copurified. One
advantage of this method is that it is possible to produce large
quantities of the fusions in E. coli, which increases the likelihood of
detecting weak interactions. Disadvantages include the difficulties of
expressing some fusions and the possible absence of essential post
translational modifications in E. coli.21
2. Identification of the Cleavage Site Recognized by the
Turnip Yellow Mosaic Virus Protease
2.1Introduction
The viral proteins required for the replication of TYMVare
encoded by ORF-206 (Fig. 1.1). The 206 kDa protein encoded by
ORF-206 contains methyltransferase-, helicase- and polymerase-
like domains, and is autocatalytically processed into p141 and p66
(previously known as p150 and p70) by its own protease domain
(Fig. 1.1). In order to better characterize the ORF-206 proteins and
their role in cis-preferential replication, it was important to identify
the peptide bond that is cleaved by the protease to form p141 and
p66. Knowledge of the cleavage site has been used in the designing
of clones used to investigate protein-protein interactions (Chapters
4 and 5).
Previous work has identified the probable active site residues
of the protease as C783 and H869, helping to classify the protease asa
papain-like protease (Bransom and Dreher, 1994). Experiments
using triple amino acid mutations across the sequence 1253-
GPKLNGATP-1261 of p206 have suggested that cleavage occurred
within this sequence (Bransom et aL, 1991), but the exact cleavage
site is unknown.
Attempts at N-terminal sequencing in vitro translated p66
labeled with [311]proline have been unsuccessful. In this study, we
hoped that [35S]methionine, with its high specific activity, would
provide a better label for sequencing. Because of the lack of
methionine residues in the N-terminal region of p66,
oligonucleotide-directed mutagenesis was used to change the
underlined residues to methionines in the wild-type p206sequence
1257-NGATPSASPTHR-1268 (performed by Kay Bransom). Since it
had been noted that small deletions in p66 resulted in higher yields
of in vitro translated p66 (Kay Bransom, unpublished observation),22
an in-frame deletion of codons 1331-1468 was also introduced to
create pTYMC-Mete66. e66 protein labeled with [35S]methionine
was subjected to sequential Edman degradation and the released
amino acids from each cycle were collected and analyzed for
radioactivity (insufficient material was present for mass detection).
The peak fractions corresponded to the two methionine residues,
and were used to deduce the TYMV protease cleavage site.
2.2Methods
2.2.1Preparation of transcripts
300 ng of linear plasmid DNA (pTYMC or derivative) was used
to make RNA transcripts using T7 RNA polymerase. The 30 ptl
reactions contained 80 mM Hepes-KOH, pH 7.5, 12 mM magnesium
chloride, 2 mM spermidine, 2.9 mM NTPs, 9 mM dithiothreitol, and
50 units T7 RNA polymerase. The samples were incubated at 37°C
for 30 minutes, then 50 more units of T7 RNA polymerase were
added, and the incubation continued another 30 min. After
treatment with E. coli deoxyribonuclease I, the transcripts were
phenol extracted, ethanol precipitated and dissolved in 50 µl water.
2.2.2In vitro translation
Transcript RNA (30 ng/µl) was translated at 30°C for 90
minutes in a rabbit reticulocyte lysate (Promega), in the presence of
0.33-0.66 iCi [35S]methionine/R1, 25 mM Hepes-KOH, pH 7.2, 40 mM
potassium chloride, 0.1 M potassium acetate, 0.5 mM magnesium
acetate, 0.1 mM spermidine, 57 µg /ml bovine liver tRNA, and 50 ILIM
each amino acid except methionine. Reaction volumes were 60 IA23
2.2.3Protein sequencing
The proteins of in vitro translations ofmutant transcripts
were separated by 0.1% SDS/10% PAGE and transferred to
polyvinylidene difluoride membrane (PVDF, DuPont)using a semi-
dry electrophoretic transfer apparatus (Semi-phor,Hoefer Scientific
Instruments) with a minimal amount of transfer buffercontaining
20 mM Tris-base, 150 mM glycine and 20% methanol.The band
corresponding to the e66 protein (51 kDa)was cut out of the PVDF
membrane and was subjected to N-terminalsequencing cycles in an
Applied Biosystems gas-phase analyzer (performedby Barbara
Robbins, Central Services Laboratory, the Center forGene Research
and Biotechnology). The fractionswere collected and counted in a
liquid scintillation counter (Packard Tri-Carb).
2.3Results and Discussion
Previous to protein sequencing, itwas determined that the
methionine substitutions introduced in the N-terminalregion of p66
did not interfere with viral replicationor infectivity (Bransom et al.,
1996). RNA transcripts of the methioninemutant genome (TYMC-
Met) and of wild type TYMCwere inoculated onto turnip plants as
previously described (Weiland and Dreher, 1989)and both
produced typical signs of infection by 5-6 days.The yield of virions
from methionine-mutant infected leaveswas similar to that of
TYMC-infected leaves. RT-PCRwas used to amplify mutant genomes
purified from the infected leaves, and theproduct was sequenced to
confirm the stability of the two methioninemutations.
Once the methionine substitutions had beenshown to be
stable and not to affect the proteolyticprocessing of p206 (as
determined by analysis of in vitro translationproducts), a large24
scale (600) in vitro translation of the pTYMC-MetA66genome was
performed. The A66 protein (51 kDa) was subjected to sequential
Edman degradation, and the fractions were analyzed for
radioactivity (Fig. 2.1). Analysis of two independently prepared
samples indicated the release of [35S]methionine in fractions 6 and
8. From this data, the cleavage site was deduced to be between
amino acids A1259 and 11260 and the molecular weights of the two
released proteins were calculated at 140,618 and 66,036 Da. The
cleavage site of the TYMV protease has been confirmed by the work
of Kadare et al. (1995).
The sequence around the cleavage site is as follows (with
cleavage occurring between P1 and P1':
P7 P6 P5 P4 P3P2P1P1'P2'P3'
GP KLNGA TPS
With the cleavage site identified, the results of previous
studies where amino acids were mutated to glycineor alanine in
triplets (Bransom et aL, 1991), now indicate that changes in the
amino acids at and immediately upstream of the cleavage siteare
the changes that will most likely reduce or prevent cleavage.
Substitution of LNG (P4 to P2) with AAA resulted inno detectable
cleavage by the protease, and the substitution of ATP (P1 to P2')
with GAA resulted in a partial loss of cleavage. The cleavage site
preferences of other papain-like viral proteases also indicate the
strongest sequence requirements are at P1 and P2, although
substitutions by related amino acids can be permissible (Carrington
and Herndon, 1992; Strauss and Strauss, 1994).
TYMV is the first tymovirus for which the exact protease
cleavage site is identified and it was hoped thatsequence
comparisons would allow predictions for cleavage sites in other
tymoviruses. However, the sequences of tymoviruses are divergent
around the cleavage site and do not allow for clear predictionsat25
this time. Direct cleavage site determinations will be required to
learn how broad a range of sites is recognized by tymoviral
proteases.
The TYMV protease cleavage site was considered in the design
of pAS1-66, pACTII-66 (Chapter 4), and pGEX-66 (Chapter 5).
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Figure 2.1. Analysis of N-terminal sequence of the internally
deleted 66 kDa protein. The graph shows the relative levels of
[35S]methionine (relative to cycle 6, taken as 1.0) recovered from
sequential cycles of Edman degradation completed by an automated
protein sequencer on two independent samples. The recovery of
[35S]methionine in two peaks separated by one cycle identifies the
methionine residues introduced into p206 at positions 1265 and
1267 and permits identification of the N-terminal residue of the
deletion derivative of the 66 kDa protein. The deduced amino acid
sequence for cycles 1-20 is indicated on the bottom.26
3. TYMV Protein Interactions: Coimmunoprecipitation
Results
3.1Introduction
As described in Chapter 1, complementation experiments with
TYMV revealed that its replication is cis-preferential. Most non-
independently replicating genomes could not be efficiently rescued
by a helper genome, as determined by the accumulation of genomic
RNA in turnip protoplasts (Weiland and Dreher, 1993). There were
some mutant TYMV genomes, however, that wereable to
accumulate to high levels when coinoculated with a genome
containing a point mutation in the helicase active site (GCGST).
These mutant genomes included eSP-G which could accumulate to
49% and e4085-4587 which could accumulate to 21% compared to
wild type (Fig. 1.2). These two genomes contained large deletions in
the p66 coding region. It was postulated that the ability of these
deleted genomes to replicate in trans related to the absence of the
usual cis-interactions proposed between viral proteins. According to
a proposed model, the newly synthesizedreplication proteins, p141
and p66, would associate with one another and with their template
(Fig. 1.3). The deletions in p66 disrupt the protein-protein
interaction, and the proteins would then be available in trans
(Weiland and Dreher, 1993). The goal of this study was to obtain
physical evidence for the hypothetical interaction between p66 and
p141.
The approach used was to perform immunoprecipitations on
in vitro translated TYMV RNAs. If p66 and p141 form a complex,
immunoprecipitations using antibodies against one protein would be
expected to coprecipitate the second protein. The objectives of these
experiments were to first determine if p141 and p66 form a
complex in vitro, and then to attempt to map the interaction domain
in p66 using nested in-frame deletion mutants. This approach was27
successful in detecting an interaction between the two BMV
replication proteins, and in mapping the interaction domain (Kao et
al., 1992a and b).
The IgG fractions of three antisera directed against synthetic
peptides were available for use. N-206 is directed against the
sequence VPEGHEAGSYNOPSDA at the N-terminal region
(methyltransferase domain) of p206, C-141 is directed against the
sequence ANGLVALYTSRSGV at the C-terminal region of p141, and
C-206 is directed against the sequence AESELLHYVQ at the C-
terminus of p206 (Fig. 3.1). It was hoped that immunoprecipitations
using each of these antibodies would coprecipitate other protein(s)
involved in the proposed complex.
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Figure 3.1. Epitopes recognized by ORF-206 specific antiserum.
This diagram of p206 shows the protease cleavage site and the
locations of the amino acid sequences corresponding to the synthetic
peptides used in antibody production.
3.2Methods
3.2.1Preparation of transcripts
300 ng of linear plasmid DNA (pTYMC or derivative) was used
to make RNA transcripts using T7 RNA polymerase. The 30 [tl28
reactions contained 80 mM Hepes-KOH, pH 7.5, 12 mM magnesium
chloride, 2 mM spermidine, 2.9 mM NTPs, 9 mM dithiothreitol, and
50 units T7 RNA polymerase. The samples were incubated at 37°C
for 30 minutes, then 50 more units of T7 RNA polymerase were
added, and the incubation continued another 30 min. After
treatment with E. coil deoxyribonuclease I, the transcripts were
phenol extracted, ethanol precipitated and dissolved in 50111 water.
3.2.2In vitro translation
Transcript RNA (30 ng/R1) was translated at 30°C for 90
minutes in a rabbit reticulocyte lysate (Promega), in the presence of
0.33-0.66 tCi [35S]methionine/R1, 25 mM Hepes-KOH, pH 7.2, 40 mM
potassium chloride, 0.1 M potassium acetate, 0.5 mM magnesium
acetate, 0.1 mM spermidine, 57 µg /ml bovine liver tRNA, and 5011M
each amino acid (except methionine). Reaction volumes were
typically 15 to 60
3.2.3Assay for label incorporated into protein
The amount of [35S]methionine incorporated into protein
during in vitro translations was determined by trichloroacitic acid
(TCA) precipitation. Aliquots (1.5 Id) of the in vitro translation
reactions were spotted on filter paper and allowed to dry. The filter
paper was then boiled in 10% TCA for ten min, rinsed twice with 5%
TCA, twice with 95% ethanol, and once with acetone. The filter
paper was then air dried, added to scintillation fluid, and counted in
a liquid scintillation counter (Packard Tri-Carb). Typical readings
were between 20,000 and 100,000 cpm/til translation reaction.29
3.2.4IgG purification
The antipeptide antisera were first de-salted by adding 1 ml
serum volumes to NAP 10 columns (Pharmacia Biotech). The serum
was eluted with 1.5 ml application buffer (20 mM Tris-HC1, pH 8.0,
and 28 mM sodium chloride). The desalted serum was added toa
DEAE Affi-blue gel column (Bio-Rad), and eluted in 20 ml
application buffer, collecting 6 fractions of approximately equal
volumes. The concentration of IgG in each fractionwas determined
by reading the absorbance at 280 nm and converting to IgG
concentration using the relationship A280= 1.35 for 1 mg/nil IgG
(Harlow and Lane, 1988). The three most concentrated fractions
were pooled and used in the subsequent experiments. The pooled
IgG fractions represent 1:6 dilutions of the originalsera.
3.2.5Enzyme immunoassay
A 20 µg /ml peptide solution in PBS (1.8 mM potassium
phosphate, 10 mM sodium phosphate, pH 7.2, 140 mM sodium
chloride, 2.7 mM potassium chloride) was used to coat the wells ofa
polystyrene microtiter plate. Fifty pl of the solutionwas added to
each well, and the plate was covered and incubated overnight at 4*
C. The plate was washed twice with wash buffer (PBS containing
0.05% Tween 20), and then the wells were filled completely with
PBS containing 2% BSA. The plate was incubated atroom
temperature for two hours, and then washed twice with wash
buffer (Fuller et al., 1988).
The antiserum to be tested was diluted 1/100, 1/400, 1/1600
and 1/6400 in diluting buffer (PBS containing 0.25% BSA, 0.05%
Tween 20, and 0.02% sodium azide). Fifty I.L1 of dilutedserum was
added to each well, and the plate was incubated atroom
temperature for 2 hours, followed by four washes with wash buffer
(Fuller et al., 1988).30
Fifty til of a 1/1000 dilution of alkaline phosphatase-
conjugated goat anti-rabbit antiserum in diluting bufferwas added
to each well. The plate was again incubated atroom temperature for
2 hours, followed by 4 washes with wash buffer,and two with
substrate buffer (10 mM diethanolamine, pH 9.5, 0.5mM
magnesium chloride). Fifty µl of a 0.1% solution ofp-nitrophenyl
phosphate in substrate bufferwas added to each well, and the plate
was incubated for 30 minutes at room temperature. The reaction
was stopped by the addition of 501A1 of 0.1 M EDTA to each well
(Fuller et al., 1988) and the platewas read at 405 nm.
3.2.6Immunoprecipitations
Between 2 and 5 R1 (100,000-150,000 incorporatedcpm) of
the in vitro translations were diluted to 80 gl withcold L buffer (50
mM Tris-HC1, pH 7.4, 50 mM potassium chloride,15 mM magnesium
chloride, 1 mM dithiothreitol and 10% glycerol)in 1.7 ml tubes.
Twenty-five pi of a 50% slurry of freshly washedProtein A-
Sepharose (Sigma) in L bufferwas added to each, and the tubes
were rotated at 4°C for 10 min. The tubes were then centrifuged for
90 seconds at 2040 x g. After this pre-adsorptionstep, the
supernatants were transferred to new tubes containing1 R1 of
antiserum or 5 IA of a purified IgG fraction, androtated 2-5 hours at
4°C. The tubes were then spun briefly, 40 IA ofthe Protein A-
Sepharose slurry was added to each, and therotation at 4°C was
continued overnight.
The Sepharose beads were washed twicewith 500 R1 cold L
buffer, once with 500 I.L1 cold 500 mM lithiumchloride, 20 mM Tris-
HC1, pH 7.4, and twice again with 500 FL1 coldL buffer (Kao et al.,
1992a). Ten µ12X Laemmli buffer (31 mMTris, pH 6.8, 4% SDS, 20%
sucrose, 0.01% bromphenol blue, 10% 13-mercaptoethanol)was
added to each tube and the tubeswere boiled for 5 min. The31
dissociated proteins were analyzed by 0.1% SDS/10% PAGE
(Laemmli, 1970).
Except where noted, the L buffer included 0.05% SDS and 0.5%
Triton X-100.
3.2.7Immunoprecipitation analysis
A phosphorimager and integration software (Image Quant,
Molecular Dynamics) was used to determine the relative amounts of
the ORF-206 proteins present in the immunoprecipitations. Some of
the protein bands were close together on the SDS-PAGE, but
chromatograms of each lane made it possible to determine the
peaks corresponding to each band. The ratio of p141/p66 corrected
for the number of methionines in each protein was determined. The
values for the ratios were similar whether peak height or peak area
were used in the calculations.
3.3Results and Discussion
3.3.1Coimmunoprecipitations with different antisera
Ideally, the immunoprecipitations would have been
performed in nondenaturing conditions so that protein complexes
would only be minimally disturbed. It was determined, however,
that SDS and Triton X-100 were required in the
immunoprecipitation buffer in order to prevent nonspecific binding
of the proteins to the Protein A-Sepharose. As shown in Figure 3.2
lanes 2-4, immunoprecipitations of in vitro translations of TYMV
transcripts using preimmune sera precipitated both p141 and p66
when the buffer did not contain both SDS and Triton X-100. Note
that these antibodies are specific when detecting SDS-denatured32
proteins (Connie Bozarth, unpublished). Other conditions tried in
order to reduce non-specific binding included adding 2% BSA in the
immunoprecipitation buffer, extending the wash times to 10 min
each, and using Protein A-acrylic beads (BioRad) instead of
Sepharose. None of these variations reduced the non-specific
binding (data not shown). The buffer used in all subsequent
immunoprecipitations contained 0.05% SDS and 0.5% Triton X-100.
While these conditions are not ideal for the study of protein-protein
interactions, they were necessary in this case and in other studies
where immunoprecipitation were successfully used to identify
protein-protein interactions (Hartley el al., 1995; Horisberger,
1992).
Immunoprecipitations using the C-206 antiserum precipitated
p206 and p66, which contain the epitope recognized by the C-206
antibodies, and to a lesser degree, p141 which does not (Fig. 3.2,
lane 7). Since the C-206 antiserum does not immunoprecipitate
p141 from in vitro translations of transcripts missing the coding
region for the C-206 epitope (ASP-W, Fig. 3.2, lane 14), it was
concluded that the p141 in Fig. 3.2, lane 7 was coprecipitated
through its interaction with p66 and/or p206.
Immunoprecipitations using the N-206 or C-141 antisera
precipitated p141, which contains both of the recognized epitopes,
but precipitated p206 very poorly (Fig. 3.2, lanes 8-13). Both of
these antisera had been shown in an immunoassay to contain
antibodies that recognized the synthetic peptides they were
directed against (data not shown) so it was surprising that neither
could efficiently precipitate p206. Possibly both epitopes are
inaccessible in the full length protein. No p66 was detected in
immunoprecipitation using either of the antisera (Fig. 3.2, lanes 10
and 13), but the amounts of p141 precipitated were fairly low. Even
if every p141 molecule precipitated was associated with a p66
molecule, the amount of p66 coprecipitated would likely be
undetectable because of its smaller molecular weight and lower
methionine content compared to p141. It is also possible that if p6633
associates with p206, it was not coprecipitated with either the N-
206 or C-141 antisera because of the lack of precipitated p206.
Another potential problem is that some or all of the epitopes
are inaccessible in a protein complex. If this is the case, then the use
of polyclonal antibodies directed against full length or domains of
the proteins would be more likely to precipitate the complexes.
Such antisera are unavailable at present.
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Figure 3.2. Immunoprecipitations of TYMC in vitro
translations. Lane 1 represents 1 lit of the [35S]methionine-labeled
in vitro translation products of TYMC transcripts. Lanes 2-13are
immunoprecipitations of 5 Rl of translation products directed by
TYMC transcript RNA, using either preimmune serum (lanes 2-4), C-
206 antiserum (lanes 5-7), N-206 antiserum (lanes 8-10)or C-141
antiserum(lanes 11-13). L buffer (L) was used in the
immunoprecipitations in lanes 2, 5, 8 and 11, L buffer with 0.5%
Triton-X 100 (LT) was used in lanes 3, 6, 9 and 12, and L buffer
with 0.5% Triton-X 100 and 0.05% SDS (LTS) was used for the
immunoprecipitations in lanes 4, 7, 10 and 13. Lane 14 isan
immunoprecipitation of 5 R1 of a ASP-W translation using C-206
antiserum and in the presence of LTS buffer.34
3.3.2Is the 3' end of the TYMC genome required for the
proposed protein complex formation?
The model for cis-preferential replication envisions the
involvement of the 3' untranslated region of the genome in either
protein complex formation or stability. For BMV, it has been found
that the 3' and intercistronic noncoding regions of RNA3 are
required, along with the replication proteins, for the formation or
the stability of active replication complexes in yeast (Quadt el al.,
1995). Since pTYMC/Hind III produces TYMC transcripts with an
extra few bases on the 3' end (ACGU) not found in the genomic RNA,
it was important to determine whether these extra bases would
interfere with protein complex formation detected as a change in
the p141/p66 ratio of the immunoprecipitations. This could occur if
complex formation required an aminoacylated 3' end. As can be
seen in Fig. 3.4, the immunoprecipitations of the translation
products of TYMC and TYMC virion RNA are very similar, and the
p141/p66 ratios are 0.28 and 0.30 respectively. So even though the
additional bases on the TYMC transcript interfere with
aminoacylation of the 3' end, this does not appear to affect protein
complex formation in this assay.
The A3' construct, linearized at Sma 16061 and therefore
missing 257 nucleotides from the 3' end of the genome, was also
used in immunoprecipitation experiments to determine the
importance of the 3' end of the TYMV genome in the formation or
stability of the proposed protein complex. The transcripts made
from this construct lack the 3' untranslated region of the genome,
which includes the tRNA-like structure. The p141/p66 ratio for the
A3' immunoprecipitation was 0.25, similar to 0.28, the ratio for
TYMC (Table 3.1). This result indicates that the 3' end of the TYMV
genome, which includes the tRNA-like structure, does not affect the
p141/p66 ratio and therefore does not appear to be involved in the
formation of the putative p141/p66 or p141/p206 complex in vitro.35
3.3.3Mapping the interaction domain in p66
Since the immunoprecipitations using the C-206 antiserum
provided some evidence for an interaction between p141 and
p66/p206, this antiserum was used in subsequent experiments in
an attempt to map an interaction domain in p66. Figure 3.3
diagrams ORF-206 for TYMC and the mutant genomes used in this
study. The clones from which these RNAs were transcribed were
constructed by Kay Bransom and David Gilmer. The ASP-G construct,
containing a deletion between nucleotides 4086 and 5422 in the
p66 coding region, allowed for efficient trans replication in turnip
protoplasts (Weiland and Dreher, 1993). Since this deletion was
proposed to disrupt the postulated interaction between p141 and
p66, the other mutant genomes used in this study contain smaller
in-frame deletions between nucleotides 4086 and 5422.
The objective was to perform immunoprecipitations on the in
vitro translations of mutant transcripts, and determine if any of the
deletions resulted in a loss or decrease in the amount of
coprecipitated p141. Figure 3.4A shows the in vitro translation
products of mutant and wild type transcripts and Figure 3.4B shows
the results of their immunoprecipitations with the C-206 antisera
using buffer containing SDS and Triton X-100.
The p141/p66 ratios for the immunoprecipitations were
determined as described in the Methods section. The p141/p66
ratio for TYMC was calculated at 0.28, which was similar to that of
many of the deletion mutants. The ratios for the deletion mutants,
ASP-G, Pst 4276 and AMP 4708 were estimated to be 0.087, 0.089
and 0.12,respectively, about three times smaller than the ratio for
TYMC. The lower ratios indicate that less p141 was coprecipitated
with these constructs. These results suggest that the common
domain missing in the three mutants, in the C-terminal half of p66,
could be involved in the proposed protein-protein interaction.36
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Figure 3.3. ORF-206 of TYMC and the modifiedgenomes used
in this study. A3' contains a wild type ORF-206 but thegenome is
linearized at Sma 16061 and lacks the tRNA-likestructure on the 3'
end. ASP-W contains a frameshift mutation and translation of this
genome produces a truncated version of p206 that is missing the C-
206 epitope. ASP-G has the region between nucleotides 4086 and
5422 deleted. The other deletion mutants are nested in-frame
deletions within nucleotides 4086 and 5422.37
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Figure 3.4. Autoradiograph of deletion mutant translations
and immunoprecipitations. Transcripts of the constructs in Fig. 3.3
were translated in vitro as described in the Methods section. The
translation products are shown in panel A, and the
immunoprecipitations are shown in panel B. The L buffer used for
the immunoprecipitations contained both 0.5 % Triton-X 100 and
0.05 % SDS. TYMC vRNA indicates that virion RNAwas used in the
translation. Proteins were separated by 0.1% SDS/10% PAGE.Construct Deletion
size
in
amino
acids
# of
met in
p141
# of
met in
p66
..
p141/metp141/p66
ratio
relative
to that of
TYMC
*relative
co-
replication
in
protoplasts
p66/met
(average +/- 1
SD) TYMC = 0 19 7 0.28 +/- 0.11 1.0 1.0 TYMC (virion) =1 0 19 7 0.30 +/- 0.016 1.1 1.0
A 3'======= 0 19 7 0.25 0.89 NA
ASP -G=nom 445 19 2 0.087 +/- 0.017031 0.54 Sal 4301 =za 72 19 7 0.29 +/- 0.013 1.0 0.12 Sal 4515 = 143 19 7 0.36 +/- 0.14 1.3 0.37 A SM 4708 a= 208 19 6 0.33 +/- 0.074 1.2 037 Sa14985 = 300 19 4 0.19 +/- 0.014 0.68 0.44
ASph======= 233 19 5 0.27 +/- 0.092 0.96 0.16
Pst 4276=31=12.m3 375 19 2 0.089 +/- 0.026032 043
Pst 4490car===mm" 304 19 2 0.12 +/- 0.044 0.43 024
AMP 4708=22m1121 208 19 3 0.18 +/- 0.052 0.64 0.49
Table 3.1. The number of methionines in p66 and p141, the size of the deletion and the ratio of
p141/p66 in the immunoprecipitation are recorded for each construct. The immunoprecipitations were
repeated at least twice for all of the constructs except A3' which was only performed once. The
calculated ratios were determined using peak heights as described in the Methods section. The relative
replication as compared to wild type was recorded for each construct. Coreplication was measured by
Northern analysis of turnip protoplasts coinoculated with the mutant transcripts indicated and
transcripts of a complementation partner (GCGST) containing a point mutation in the helicase active site.
*Data of Kay Bransom.39
Two of the deletion mutants, Sal 4985 and AMP 4708, have
p141/p66 ratios (0.19 and 0.18 respectively) that are lower than
that of TYMC, but not as low as the ratios for Pst 4276, Pst 4490 and
ASP-G. All the other deletion mutants (Sal 4301, Sal 4515, ASM
4708. and ASph), have ratios similar to that of TYMC. The result of
AMP 4708, with its lower than wild type p141/p66 ratio, is in
agreement with the findings from the ASP-G, Pst 4276 and AMP
4708 genomes that indicated the C-terminal half of p66 contains a
possible interaction domain. The deletion in Sal 4985 (A4085-4985)
is very similar to the deletion in ASph (A4280-4980) but their ratios
are different (0.19 and 0.27 respectively). The 195 nucleotides that
are present in ASph but missing from Sal 4985, are also missing in a
number of the other mutants (Sal 4301, Sal 4515, and ASM 4708)
that have ratios similar to TYMC, so it is unlikely that the
nucleotides correspond to an interaction domain. Lower recovery of
p141 could be due to overall structural changes in p66 caused by
the A4085-4985 deletion.
A factor that complicates the deletion mapping is that some of
the p141 in the immunoprecipitations could be present due to its
non-specific binding to the Protein A-Sepharose and not necessarily
due to its specific interaction with p66/p206. Although the non-
specific binding of p141 to the Protein A-Sepharose was greatly
reduced by the addition of Triton X-100 and SDS to the
immunoprecipitation buffer, some p141 did continue to bind non-
specifically (Fig. 3.2, lane 4). The small amount of p141 that binds
non-specifically to the Protein A-Sepharose would be expected to be
similar in all of the immunoprecipitations of mutant genomes.
However, since the amount of p141 coprecipitated was relatively
small, especially with some of the deletion mutants, any variations
in the amount of p141 in the immunoprecipitations due to non-
specific binding could skew the p141/p66 ratios.
It is also possible that since none of the deletions resulted in a
complete loss of the coprecipitation of p141, only a lowering of
p141/p66 ratio compared to wild type, p66 regions outside the40
deletion between nucleotides 4086 and 5422 could be involved in
the protein-protein interaction.
Table 3.1 also contains the results of coreplication
experiments performed by Kay Bransom. These complementation
experiments in turnip protoplasts used the mutant transcripts
together with a complementing transcript that contains a point
mutation in the helicase active site (GCGST) as inocula. It was hoped
that these complementation experiments would help map a domain
whose absence promotes trans-replication, and that this
phenomenon could be correlated to the postulated protein-protein
interaction domain of p66. Genomes with deletions that
corresponded to an interaction domain would be expected to be
efficiently rescued by the GCGST genome. It was hoped that the
results of these experiments would lend support to the
immunoprecipitation results that suggest the involvement of the C-
terminal region of p66 in an interaction with p141/p206. However,
the coreplication results show that any deletion in the p66 coding
region resulted in an increase in the accumulation of genomic RNA
as detected by Northern analysis, indicating complementation with
the GCGST genome. As described in Chapter 1, coreplication
experiments with GCGST transcripts and transcripts containing a
polymerase point mutation (RDD), resulted in replication levels of
2% compared to wild type (or 0.02 relative replication). The data
summarized in Table 3.1 show that the smallest deletion in p66 (Sal
4301) resulted in an increase in the relative replication from 0.02 to
0.12. ASP-G, which contains the largest deletion, could accumulate to
levels up to 0.54 relative to wild type.
It is possible that many of the deletions in p66 result in
improper folding of the protein that distorts the interaction domain
and hinders the ability of p66 to interact with p141. This could
explain the coreplication experiments where all the deletion
mutants were more efficiently rescued than was the RDD mutant.
Although most of the immunoprecipitation data does not support
the idea that the deletions disrupt proper protein folding (many of
the deletion mutations had p141/p66 ratios similar to TYMC), the41
difference in the ratios between the Sal 4985 andASph genomes,
even that the deletions are very similar, could be explained by
potential differences in the folding of themutant p66 proteins.
Another explanation for the coreplication resultsis that the
proposed interaction domain of p66 is formed bythe tertiary
structure of the protein, such as with the SH2 and SH3 domainsof
Src (Yu et al., 1992) where a hydrophobic pocketis formed on the
surface of the protein. If thiswas the case, the interaction domain
would not map as one domain detected in theprotein's primary and
secondary structure. Any deletion could potentiallyaffect the
protein's conformation and weaken its interaction withp141. It is
also possible that there are multiple interactiondomains in p66.
3.3.4Conclusions
The immunoprecipitation datagave some indication that p141
and p66/p206 could forma complex in vitro. The attempt to map
the interaction domain with immunoprecipitationsof the translation
products of deletion mutants led to the conclusionthat the C-
terminal half of p66 may be involved in theprotein-protein
interaction. The immunoprecipitation results could bemisleading,
however, due to variations in the smallamounts of p141 that bind
nonspecifically to the Protein A-Sepharose, andto potential
problems the deletions cause in protein folding.The coreplication
experiments where all deletions resulted in increasedtrans
replication, do not lend support to the involvementof any particular
domain in an interaction. As discussed in Chapter1, it is important
to use more than one method when investigatingprotein-protein
interactions. Since the immunoprecipitation datagave some
indication of an interaction between in vitrotranslated p141 and
p66/p206, a yeast two-hybrid systemwas used next to verify the
interaction.42
4. TYMV Protein Interactions: Yeast Two-Hybrid Results
4.1Introduction
In the yeast two-hybrid system (Fields and Song, 1989), the
ability of two hybrid (chimeric or fusion) proteins to interact
correlates with the transcriptional activation of a reporter gene.
This system is commonly used to search a library of fusion proteins
for ones that interact with a bait protein. In this study it was used
to determine if two known proteins interact. In contrast to the in
vitro immunoprecipitations described in Chapter3,the yeast two
hybrid system is an in vivo genetic method. It was hoped that the
study would provide data in support of the immunoprecipitation
data indicating that p141 andp66/p206could form a complex in
vitro.
The E. coli/yeast shuttle vectors used in this study are shown
in Figure 4.1. pAS1 (Durfeeet al., 1993)is a 7.1 kb plasmid with a
TRP1 selectable marker (encodes Aq5'-phosphoribosyl)-
anthranilate isomerase Plischkeet al., 1976and can restore
tryptophan prototrophy in a yeast host) and a 2 micron origin of
replication. The plasmid contains an alcohol dehydrogenase 1
(ADH1)promoter followed by the coding region for the Ga14 DNA
binding domain containing a nuclear localization signal, a
hemagglutinin (HA) epitope and a multiple cloning site. These
features allow for in-frame cloning into the multiple cloning site
and the synthesis of Gal4 DNA binding domain fusion proteins in an
appropriate yeast strain.43
pACTII (Durfee et al., 1993, modified by Stephen El ledge) isa
7.55 kb plasmid with a LEU2 selectable marker (encodes 2-
isopropylmalate dehydrogenase, Plischke et al., 1976) and can
restore leucine prototrophy in a yeast host. An ADH1 promoter is
followed by coding regions for a SV40 large T antigen nuclear
localization signal, the Gal4 activation domain, and an HA epitope.
Fusion proteins with the Gal4 activation domain can be created by
in-frame cloning into the multiple cloning site and usingan
appropriate yeast strain.
Ap 2 micron
on
pAS1
7.1 kb
TRP1
Terminator
5.11 44172)
Unlit
Surf
SRI
Neel
NLS
RA GALA
(1-1471P
ADH
fl+
on
t4441(4344)
&onkel*
Sfl i
CAT ATG GSSLAICIAAG G
Ncial Ncol C6-01C1C141"anill
011 BEN
Omni
RIR
NM a
SR
Seeit101
2 micron
on
LEU2
CAT ATG GCC ATG GAG GCC CCG GGG ATC CG A ATT CGA AG C TCG AGA GAT CT
Nd.I Ncol SmalHamill EcoRI Xhol Egli I
Figure 4.1. Diagrams of pAS1 and pACTII. These diagrams,
adapted from Durfee et al. (1993), include restriction sites and
sequences of the multiple cloning sites.44
Both plasmids also contain ampicillin resistance genes and
origins of replication that allow for cloning, selection and growth in
E. coll.
The approach was to use pAS1 and pACTII to make fusion
proteins with the ORF-206 proteins of TYMV and to test their ability
to interact in the Saccharomyces cerevisiae strain Y166. If the
fusion proteins interact, then the Gal4 DNA binding domain and the
Gal4 activation domain would activate transcription of the
chromosomal lac Z reporter gene of Y166.
4.2Methods
4.2.1Construction of plasmids used in the yeast two-
hybrid study
Oligonucleotides were designed that, with pTYMC (or one of its
derivatives) as template, allowed for the PCR synthesis of the
inserts used in the construction of the plasmids employed in this
study. The p66 insert was created by using the pTYMC-derived
template pTYC H3-Nco (linearized), which contains an Nco I site at
nucleotide 3864, the 5' wild type sequence oligonucleotide
TYS+3825 (GTTCCCGCAACTCAAGCT) and the 3' oligonucleotide Xho-
5610(GGGCTGATTGCCTCGAGACGTAGTGAAGCA) that creates an Xho
I site at nucleotide 5627. The TYMV insert containing the conserved
helicase domain was created by using the 5' oligonucleotide
2768+Nco (ATCAGAGCCATGGAGTCTITCAAAGT) which creates an
Nco I site at 2775, and the 3' oligonucleotide Xho-3857
(GCGCTGGGGCTCGAGCCGCCGITGAGTTT) which creates an Xho I site at
3872. In the p141 insert, the wild type Nco I site at nucleotide 209
was eliminated and the Nco I site at nucleotide 93 was created by
the synthesis of a mega primer (Sarkar and Sommer, 1990) using45
the 5' oligonucleotide 84+Nco(GCAAATGAGCCATGGCCTTCCAATTAG)
and the 3' oligonucleotide 199-NcoX
(CTTCGGAATGGACCAGGGGTAGGTCTGT)that removed the wild type
Nco I site without changing the amino acid sequence of the
translated protein (the wild type codon CCA is changed to CCC; both
code for proline). The resulting 110 base pair mega primer was
used along with the 3' oligonucleotide Xho-3857 to create the full
length p141 insert. The bases that are underlined in the above
sequences indicate changes from the wild type sequence. The
inserts were digested with Nco I and Xho I and ligated to pACTII
cut with Nco I and Xho I, and to pAS1 cut with Nco I and Sal I (Fig.
4-2).
Both the helicase and the p141 inserts have a wild type Xho I
site at nucleotide 3278. Complete digestion with Nco I, and partial
digestion with Xho I followed by gel purification provided the full
helicase insert. Complete digestion of the p141 insert with Xho I
created the p141-XF insert. The nucleotide 3278-3872 Xho I
fragment was ligated to pACTII-141-XF cut with Xho I to create
pACTII-141. The p141 insert used to create pAS1-141 was
provided by digestion of pACTII-141 with Nco I followed by a
partial digest with Xho I (Fig. 4.2). The above ligation reactions were
used to transform E. coli strainDH5ausing standard molecular
biology techniques (Maniatis et al., 1988). The transformants were
then screened for the presence of vectors containing the above
inserts as determined by diagnostic restriction digests of the
plasmidDNA.
4.2.2Polymerase chain reaction (PCR)
PCR was used to synthesize the inserts used in the yeast two-
hybrid constructs. Ten pmoles of each oligonucleotide and 100ng of
template were combined in 10 p.1 reactions containing50mM Tris,
pH 8.5, 2 mM magnesium chloride, 500 µg /ml BSA, 0.2 mM dNTPs46
and 0.5 units of Taq DNA polymerase (Promega). The samples were
transferred to capillary tubes and placed in an Idaho Technologies
air thermo-cycler. Typical temperature conditions were:
Denaturation at 94°C for two minutes before cycling 30 times
between 50-60°C for one second, 72°C for 20-150 seconds and 94°C
for one second. Taq was the polymerase used for the p66 and
helicase inserts. Because of the enzyme's proofreading capabilities,
rTth DNA polymerase (Perkin-Elmer), was used at 1 unit per 10 pl
reaction, and using an elongation temperature of 68° instead of
72°C, for the p141 3.8 kb insert synthesis
4.2.3Yeast transformations
Strain Y166 is a S. cerevisiae strain with the genotype MATa,
ga14, ga180, his3, trp1-901 ade2-101, ura3-52, leu2-3, leu2-112,
rnr3:GAL1--->URA3 (GALL-lacn Y166 was grown in 2-10 ml YEPD
(2% peptone, 1% yeast extract, 2% glucose) overnight at 30°C. The
culture (1.5 ml) was transferred to a microfuge tube, and
centrifuged 16,000 x g for 20 seconds to pellet the cells. The
supernatant was discarded and the pellet was resuspended in the
residual medium. Between 1 and 5 tug of plasmid DNA, 50 lig single
stranded carrier DNA and 500 µl of polyethyleneglycol solution (10
mM Tris-HC1, pH 7.5, 40% PEG 8000, 1 mM EDTA, 0.1 M lithium
acetate) was added to the cells. The cells were incubated at 30°C for
15 min on a shaker, followed by incubation in a 42°C water bath for
10 min. Ethanol was added to 10% and the cells were incubated
another 5 min at 42°C (Lauermann, 1991). The cells were then
pelleted, resuspended in 200 R1TE (10 mM Tris-HC1, 1 mM EDTA, pH
7.5), plated on the appropriate dropout medium (medium lacking an
essential amino acid) and incubated at 30°C for 3-5 days. The
dropout media were composed of 0.17% yeast nitrogen base, 0.5%
ammonium sulfate, 2% glucose, and 0.15% of an amino acid mix that
excludes leucine, tryptophan, histidine and uracil. A filter-sterilized47
solution of uracil was added to a concentration of 50 mg/1, and
leucine, histidine and tryptophan were added where appropriate to
concentrations of 100 mg/1, 200 mg/1, and 50 mg/1 respectively.
Transformations for the double transformants were done
sequentially; ie. the yeast strain was transformed with one plasmid,
and a single yeast colony was picked to liquid medium and grown
overnight at 30°C before being transformed with the second
plasmid. It was found unnecessary to grow the single transformants
in selective liquid medium before performing the second
transformations.
4.2.4Recovery of plasmids from yeast
Yeast double transformants were grown overnight at 30°C in 2
ml of -leu,-trp dropout medium. The cultures were transferred to
microfuge tubes and centrifuged 16,000 x g for 20 seconds to pellet
the cells. The pellets were resuspended in the residual medium and
then vortexed for 2 min with 200 ttl lysis solution (10 mM Tris, pH
8.0, 2% Triton X-100, 1% SDS, 100 mM NaCl, 1 mM EDTA), 200 R1
phenol/chloroform, and 1 scoop (approx. 0.3 g) 425-600 [tm glass
beads. The tubes were then centrifuged at 16,000 x g for 5 min. The
supernatants were transferred to new tubes, and the DNA was
precipitated with ethanol and then resuspended in 30 µl of TE with
ribonuclease (Bartel et al., 1993). Between 1 and 10 µl of the DNA
was used to transform calcium chloride competent E. coli strain
DH5 a (Maniatis, 1988).48
4.2.5 13-galactosidase assays
Yeast colonies were initially screened for p- galactosidase
activity by a filter paper assay. A sterile 7 cm-diameter Whatman
1MM filter paper was placed on top of 4 day-old yeast colonies. A
sterile needle was used to make three orienting holes in the paper
and agar. The filter was then placed in liquid nitrogen, colony side
up, for 5 seconds. The filter paper was then transferred to a 8 X 8
cm Whatman 3MM paper soaked in Z buffer (100 mM sodium
phosphate, pH 7.0, 1 mM magnesium sulfate, 10 mM potassium
chloride) containing 0.27% ii-mercaptoethanol and 0.03% (v/v) 5-
bromo-4-chloro-3-indolyl-p-D-galactopyranoside (X-gal), and
incubated overnight at room temperature in a humid environment.
Colonies producing p- galactosidase turn blue within this time (Bartel
et al.,1993).
f- galactosidase activity was quantified using the substrate o-
nitrophenyl-p-D-galactopyranoside (ONPG). Yeast transformants
were incubated overnight at 30°C in the appropriate dropout
medium. The optical density of the cultures at 600 nm was then
measured, and 100 [L1 of each was transferred to 1.7 ml microfuge
tubes. Seven hundred µl of Z buffer/p-mercaptoethanol, 50 R1
chloroform, and 50 !al 0.1% SDS was added to each tube, and the
tubes were vortexed for 30 seconds. One hundred and sixty Rl of an
ONPG solution (0.4% in Z buffer) was added, the tubes were mixed,
and then incubated at 30°C for one hour. The reactions were
stopped by the addition of 400 !Al of 1 M sodium carbonate, and the
tubes were centrifuged at 16,000 x g for 10 min. The OD420 was
measured for the supernatants, and the f- galactosidase activity was
calculated using the following equation from Bartelet al.,(1993):
W420
p-galactosidaseunits=1000x
60 min x 0.1 ml x OD60049
4.2.6Analysis of fusion protein expression in yeast
Overnight cultures of Y166 single transformants were used to
inoculate 5 ml of the appropriate dropout medium to 0D600 %0.15.
These tubes were incubated with shaking at 30°C until the
CD60000.5 (about 6 hours). A total of 3 ml of each culture was
centrifuged at 16,000 x g for 1 minute, and the pellets were
resuspended in 50 µl of 2X Laemmli sample buffer (31 mM Tris, pH
6.8, 4% SDS, 20% sucrose, 0.01% bromphenol blue, 10%13-
mercaptoethanol). The samples were frozen at -80°C, boiled for 5
min and then centrifuged briefly (Golemis et aL, 1996). Twenty gl of
each sample were subjected to 0.1% SDS/10% PAGE (Laemmli, 1970)
followed by semi-dry electrophoretic transfer (Semi-phor, Hoefer
Scientific Instruments) to polyvinylidene difluoride membrane
(PVDF, DuPont) using a minimal amount of transfer buffer
containing 20 mM Tris-base, 150 mM glycine and 20% methanol.
The PVDF membrane was blocked for a minimum of 30 min at
room temperature in MTBS which contains 20 mM Tris-HC1, pH 7.5,
0.5 M sodium chloride (TBS) and 5% Carnation instant non-fat milk.
The blocking was followed by an incubation in a 1:1000 dilution of
anti-HA monoclonal antibodies (Berkeley Antibodies) in MTTBS
(MTBS with 0.5% Tween-20) for 2 hours. The membrane was then
washed twice with TTBS (TBS with 0.5% Tween-20) followed by a 1
hour incubation in a 1:5000 dilution of horseradish peroxidase-
conjugated goat anti-mouse IgG (BioRad) in MTTBS. The membrane
was washed twice in TTBS and twice in TBS before detection of the
peroxidase with ECL (Amersham) chemiluminescent reagents.
4.2.7His3 assay
S. cerevisiae strain CG-1945 has the genotype MATa ura3-52,
his3-200, ade2-101, lys2-801, trp1-901, leu2-3, 112, ga14-542,50
ga180-538, cyhr2, LYS2::GAL1 uAs-GAL1TATA-HIS3, URA3::GAL417-
mers( x3 )-CYC1TATA-laCZ(Clontech, 1996) and was used for the
screening of the ability of transformants to activate transcription of
the HISS gene. In order to determine the amount of 3-aminotriazole
(3AT) required to counteract the low level of constitutive His3
expression, media lacking leucine, tryptophan, and histidine, and
containing varying amounts of 3AT were used. The double
transformant pAS1/pACTII was used as the negative control and
pAS1-LEF5/pACTII-LEF5 was used as the positive control. LEF5 of
Autographa californica nuclear polyhedrosis virus (AcMNPV) is a
protein known to dimerize (Steve Harwood, personal
communication). A colony of each control was suspended in
separate tubes containing 50 ILL1 of sterile water. A sterile loop was
used to streak these suspensions on media containing varying
amounts of 3AT; the plates were incubated at 30°C for three days
and then analyzed for growth. It was determined that 3 mM was
the minimal amount of 3AT that prevented the growth of the
negative control. Media containing 3 mM 3AT were used to screen
for the expression of His3 in selected double transformant
combinations.
The His3 assay was performed on double transformants in a
similar manner as above. Suspensions of yeast colonies were made
in sterile water. Four suspensions of each double transformant,
along with one positive and one negative control, were streaked
onto the assay medium. The plates were analyzed for growth after
incubation at 30°C for three days.
4.3Results and Discussion
4.3.1 p-galactosidase assays
The fusion proteins made and screened in this study are
shown in Figure 4.2. All single transformants and all possible51
combinations of double transformants of S. cerevisiae strain Y166
were analyzed for p-galactosidase expression using a filter paper
assay that employs X-gal as a substrate. The positive control used in
these assays was pAS1 -IE1; IE1 of the baculovirus AcMNPV fused
to the GAL4 DNA binding domain can activate f- galactosidase
expression in Y166 independently of the expression of the GAL4
activation domain (Steve Harwood, personal communication). In all
cases except the positive control and the transformant
pAS1/pACTII-141, the colony lifts remained whiteor pale pink. The
lifts from the positive control began to turn blue within 30 minutes,
and the lifts from the transformant pAS1/pACTII-141 turned blue
by the following morning. The transformant pAS1/pACTII-141was
negative for p-galactosidase expression in the liquidassay using
ONPG as substrate. Since X-gal is more sensitive than ONPG for the
detection of p-galactosidase, the filter paperassay often detects
weak positives that the ONPG assay cannot detector quantify
(Clontech,1996).
Both false positives and false negatives canoccur with the
yeast two-hybrid system (Bartel et al., 1993). False positives can
occur if one fusion protein can activate transcription of lac Z (or
other reporter gene) on its own. The p141-Gal4 activation domain
fusion seems to be able to interact with the Ga14 DNA binding
domain, as the transformant pAS1/pACTII-141 turned blueover
time in the filter paper assay. However, the p141-Ga14 activation
domain fusion was not able to interact with the Gal4 DNA binding
domain-ORF-206 fusions. False negativesare also possible and can
be due to the failure of the inserts to be maintained in theyeast,
poor fusion protein expression or stability, improper fusion protein
folding, and the failure of the fusions to locate to the nucleus (Bartel
et al., 1993). Another possible reason for a negative result is that
the proteins do not interact strongly enough to be detected with this
system.MTR Pro
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Figure 4.2. Diagrams and predicted molecular weights of the
fusion proteins produced by pAS1, pACTII and the constructs with
TYMV inserts used in the yeast two-hybrid analysis. The fusion
proteins encoded by the pAS1-66 and pACTII-66 constructs include
amino acids 1257 to 1844 of p206 (the entire p66). The fusions
encoded by pAS1-hel and pACTII-hel include amino acids 894 to
1259 of p206. The helicase-like domain consists of amino acids 960-
1198 of p206. The 141-XF constructs encode fusions that include
amino acids 1-1061 of p206, and the 141 constructs, amino acids 1-
1259 of p206, the entire p141. All of these constructs create fusion
proteins comprising the Ga14 DNA binding domain or activation
domain, an HA epitope and the insert protein.53
4.3.2Insert stability and expression
In order to determine whether the inserts were maintained in
the pAS1 and pACTII vectors throughout their analysis in Y166, the
vectors were shuttled back into E. coli, and digested with restriction
enzymes to confirm the presence and size of the inserts. The
plasmids were purified from three Y166 colonies of each of the
following four double transformants: pAS1-66/pACTII-141, pAS1-
hel/pACTII-141-XF, pAS1-141-XF/pACTII-hel, and pAS1-
141 /pACTII -66. The total of twelve Y166 plasmid preparations
were used to transform E. coli. The plasmids were repurified from E
coli and digested with restriction enzymes to confirm thepresence
of inserts of the correct size. In all cases, the plasmidswere found to
have maintained the full-size inserts (Fig. 4.3).
Toxicity of the fusion proteins in either E. coli or in yeast did
not seem to be a problem as there was not a noticable difference
between the growth of cultures transformed with pAS1 and pACTII
with or without TYMV inserts.
Both the pAS1 and pACTII vectors produce fusion proteins
that contain HA epitopes (Fig. 4.2). Monoclonal anti-HA antibodies
were used to detect the fusion proteins by western analysis so as to
determine if some fusions were not being expressed,or were
unstable. Both vectors alone produced proteins of the expected size,
as did pACTII-66, pACTII-hel, and pAS1-hel (Fig. 4.4). No fusion
protein expression was detected for pAS1-66, pAS1-141, pAS1-
141-XF, pACTII-141 and pACTII-141-XF (Fig. 4.4). If the fusions
were expressed, they did not accumulate to high enough levels to be
detectable with these methods. It is unknown whether the
synthesis of the fusions was extremely low, or whether the proteins
were degraded. Multiple bands were detected in the pACTII-66,
pACTII-hel, and pAS1-hel extracts (Fig. 4.4) which could be dueto
degradation. The use of C-206, N-206 and C-141 antisera (Fig. 3.1)
were not useful in the detection of ORF-206 fusion proteins
produced in yeast because the antisera also react withmany yeast
proteins.54
Figure 4.3. Insert stability in pAS1 and pACTII. These
ethidium bromide-stained 1% agarose gelsrepresent some of the
digests performed on the plasmids shuttled backto E. coli from the
yeast strain Y166. The plasmids were identified by the fragments
produced by the digestions shown in this figure, and bya second
digestion not shown. Lane 1 in each panel isa digestion of the
corresponding plasmid before being transformed into Y166and is
included as a reference. Lanes 2-4are digested plasmids rescued
from three separate yeast colonies. pAS1 containsa BglII site (not
shown in Fig. 4.1) on the ADH promoter side of themultiple cloning
site. Since all the ORF-206 inserts contained Bgl II sitesnear the 3'
ends, Bgl II proved to be a useful screeningenzyme. pAS1 also
contains a Pst I site on the terminator side of the multiplecloning
site, not shown in Fig. 4.1. pACTII contains Bgl II siteson either side
of the multiple cloning site and itwas used for the screening of
pACTII-66 which contains an internal Bgl II site. HindIII
recognizes two sites in pACT II, one on either side of the multiple
cloning site. The plasmids in panel (A)were identified as the pAS1
derived plasmids and those in panel (B)were identified as the
pACTII derived plasmids. M is a 1 kb ladder (Gibco-BRL).A pAS1-66/BglIl pAS1-hel/BglIl
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Figure 4.4. Fusion protein expression in yeast. Extracts of Y166
transformed with pAS1, pACTII, or one of their derivatives,were
obtained and immunoblotted with anti-HA antibodiesas described
in the Methods section. The expected protein sizesare given at the
bottom of each lane in kDa.57
There is the possibility that the fusion proteins are unable to
reach the nucleus, and therefore cannot activate transcription of the
reporter genes. The fusions encoded by pAS1 and pACTII both
contain nuclear localization sequences, but it is unknown how well
the fusions used in this study were able to reach the nucleus. Since
TYMV replicates in the cytoplasm of plants, its replication proteins
may be somehow unsuitable to enter the yeast nucleus. The ORF-
206 fusion proteins may interact with yeast cytoplasmic proteins
which in turn prevents them from entering the nucleus. It is also
possible that the Gal4 DNA binding domain does not bind the GAL
upstream activation sequence (UASG) as well when expressed as a
fusion as when it is expressed on its own. It has been determined
that most LexA (a DNA binding protein that is used in the place of
the Ga14 DNA binding domain in yeast two-hybrid studies) fusions
expressed in yeast do not bind their operator as well as does native
LexA (Golemis and Brent, 1992).
4.3.3His3 assays
In order to examine the possibility that the fusions interact
only very weakly, another S. cerevisiae strain, CG-1945, that is
more sensitive to weakly interacting proteins (Craig Giroux,
personal communication) was used. With this strain, the HIS3 gene
was used as the reporter. Because the transcription of this gene,
under the control of a GAL1 promoter, is somewhat leaky, 3-
aminotriazole (3AT) was added to the yeast media to counteract any
constitutive expression of His3. 3AT is an inhibitor of imidazole
glycerol phosphate dehydratase, an enzyme involved in histidine
synthesis and encoded by HIS3 (Plischke et al., 1975). It was found
that 3 mM was the minimal amount of 3AT that prevented the
growth of a negative control (pAS1/pACTII) and allowed the growth
of a positive control (pAS1-LEF5/pACTII-LEF5) on minimal medium
plates lacking leucine, tryptophan, and histidine. These minimal58
medium plates containing 3 mM 3ATwere used to screen the
double transformants in Table 4-1. The transformantcombinations
include the pAS1-66 and pACTII-66constructs with each of the
other ORF-206 containing constructs. None ofthe transformants
were able to grow on the histidine dropout plates, indicatingthat if
the fusions were expressed andwere stable, they did not detectably
interact.
Double transformant Growth on -Ieu, trp dropout
media
Growth on -Ieu, trp, his
dropout media with 3 mM 3AT
pAS1-LEF5/pACTII-LEF5 I yes I yes
pAS1-66/pACTII-hel yes no
pAS1-66/pACTI1-141-XF yes no
pAS1-66/pACTI1-141 yes no
pAS1-hel/pACTII yes no
pAS1-hel/pACTII-66 yes no
pAS1-hel/pACTII-hel yes no
pAS1- 141 -XF /pACTII -66 yes no
pAS1-141/pACTI1-66 yes no
Table 4.1. His3 assay results. This tablelists the double
transformants of S. cerevisiae strain CG-1945that were assayed for
His3 expression by their ability togrow on media lacking histidine.
The transformants in bold indicatethat fusion proteins were
produced at detectable levels in S.cerevisiae strain Y166.
4.3.4Conclusions and future plans
Since the helicase- and polymerase-likeproteins of BMV have
been shown to interact (Kao et al., 1992,O'Reilly et al., 1995), these
two domains of TYMV seemed the most likelycandidates for a
proposed protein-protein interaction.In the yeast two-hybrid
system, the double transformant pAS1-hel/pACTII-66was the most
hopeful to activate transcription of thereporter gene because the59
fusions contained the helicase and polymerase domains, and their
expression was high enough to be detected by western analysis (Fig.
4.4). No interaction was detected, however, with this double
transformant in either of the yeast strains. Although there are
reasons why this result could be a false negative, it is an indication
that the helicase domain of p141 is not involved in an interaction
with p66.
The proposed p141/p66 protein-protein interaction may be
unlike that of BMV, and may involve the polymerase interacting
with a region of p141 outside the helicase domain. The helicase
domain was the only region of p141 that was expressed to a
detectable level in Y166. The failure to detect expression of any of
the fusions from the clones containing the large p141 and p141-XF
inserts, and the successful expression of the fusions from the clones
containing the smaller helicase insert, is an indication that smaller
fusions are more likely to be expressed in Y166. With this in mind,
more constructs have been designed that will express smaller
domains within p141. These include a clone that will expressa
methyltransferase fusion, a protease fusion, and a third fusion that
includes the region between the methyltransferase and protease
domains. It is hoped that the clones will allow the expression of
p141 domains and will lead to information on the postulated
interaction between p141 and p66.60
5. TYMV Protein Interactions: GST Fusion Results
5.1Introduction
Glutathione S-transferase (GST) fusion interaction experiments
are a popular way to look at protein-protein interactions. They were
used in this study, along with the immunoprecipitations and yeast
two-hybrid assays described in the previous Chapters, to examine
the postulated interaction between p66 and p141 of TYMV. There
are two parts to these experiments. First, one protein is expressed
as a GST fusion in a host, generally E. coli, although other hosts can
be used. Since GST has a high affinity for glutathione, the fusion
protein can be readily purified in nondenaturing conditions by
adsorption to glutathione-agarose (Smith and Johnson, 1988). The
second part of the experiments is to add in vitro translated proteins,
or alternatively a cell lysate, typically radiolabeled, to the purified
GST fusion bound to the glutathione-agarose. It can then be
determined if any proteins specifically adhere to the fusion protein.
The objectives of these experiments were to obtain sufficient
levels of expression of GST-ORF-206 protein fusions, to partially
purify the fusions on glutathione-agarose (Sigma), and to determine
if [35S]methionine-labeled, in vitro-translated ORF-206 proteins
could specifically bind to the fusions.
5.2Methods
5.2.1Construction of plasmids used to create GST fusion
proteins
The vector used in this study is a modified version of pGEX-
CS1 (a gift from Dr. Bill Dougherty, Fig. 5.1). pGEX-CS1 is a derivativeof pGEX-1 (Smith and Johnson, 1988) and has the GST coding
sequence from Schistosoma japonicum, the coding sequence for the
cleavage site of tobacco etch virus (TEV) nuclear inclusion a (NIa)
proteinase, and TEV nucleotides 145-200 all under the control of a
tac promoter (Ptac). This vector also contains a lac Fi gene and an
ampicillin resistance gene.
cleavage site sequence:
pGEX-CS1 MCS pGEX-Sal MCS
Sac I Sac I
Kpnl Kpnl
mpr Sma I Sma I
BamH I Sal I
Smal Smal
EcoR I EcoR I
E NL YFQG AM AL
GAG AAT CTT TAT TTT CAG GGC GCC ATG GCA CTG
Ehe I
Nco I
61
Figure 5.1. Map of pGEX-CS1. This 5 kb vector contains a GST
coding region fused to a sequence encoding a NIa proteinase
cleavage site. Following the cleavage site is nucleotides 145-200 of
TEV cDNA and a multiple cloning site (MCS). The MCS is shown in
more detail on the right, where the MCS of pGEX-Sal is also included
(the BamH I site has been replaced by a Sal I site). The cleavage site
sequence is shown in detail, and includes the amino acids encoded
and two restriction endonuclease sites. The asterisk (*) indicates the
peptide bond that is cleaved by TEV NIa proteinase.
A Sal I 8mer phosphorylated linker (Promega) was inserted in
the multiple cloning site of pGEX-CS1 in order to facilitate further
cloning (Fig. 5.1). pGEX-CS1 was first digested with BamH I, followed62
by treatment with Klenow (USB) and dNTP's to create blunt ends.
pGEX-Sal was created by ligating approximately 50 ng of pGEX-CS1
and 25 pmol of the Sal I linker. pGEX-Sal allowed for the forced in-
frame cloning of the inserts from the yeast two-hybrid study into
the Nco I and Sal I sites of pGEX-Sal, and the deletion of TEV
nucleotides 145-200 from the resulting constructs (Fig. 5.2).
5.2.2Expression of GST fusion proteins and their
purification with glutathione-agarose
E. coil strain DH5a transformed with pGEX-Sal or one of the
constructs in Figure 5.2, was grown overnight at 30°C in 2 ml of 2YT
containing 50 Rg/mlampicillin. The overnight culture was then
added to 100 ml of 2YT with ampicillin, and incubated at 30°C until
theOD6000.5 (about 6 hours). Isopropyl p-D-thiogalactoside
(IPTG) was added to a concentration of 0.1 mM, and the incubation
was continued for 8-16 hours. The cells were pelleted, resuspended
in 5 ml of cold PBS (10 mM sodium phosphate, 1.8 mM potassium
phosphate, pH 7.2, 0.14 M sodium chloride, 2.7 mM potassium
chloride), aliquoted 1 ml per tube, and stored at -80°C (Smith and
Corcoran, 1990).
On the day an interaction experiment was planned, 1 ml of the
above induced culture was thawed on ice. The cells were lysed by
sonicating for one minute in 5 second bursts. Lysis of the cells was
confirmed by microscopic examination. Triton X-100 was added to
1%, and the tube was mixed gently for 30 min at room temperature.
The tube was then centrifuged 16,000 x g for 10 min at 4°C, and the
supernatant was transferred to a new tube. One hundred µl of a 50%
slurry of glutathione-agarose (Sigma) in PBS was added to the tube
of supernatant, and the tube was rotated at room temperature for
0.5-1 hour. The agarose beads were washed three times with 1 ml
volumes of PBS, and then resuspended in 50 Ill PBS to give a total of
100 1i1 of slurry (Smith and Corcoran, 1990).63
5.2.3Preparation of competitor proteins
The interaction assays were performed in thepresence of
competitor proteins to inhibit nonspecific protein binding. E. coli
strain DH5a was grown overnight at 37°C in 250 ml of 2YT. The cells
were pelleted and then resuspended in 2.5 ml of BB buffer (50 mM
potassium phosphate, pH 7.5, 150 mM potassium chloride, 10 mM
magnesium chloride). The cells were sonicated five times forone
min each, alternating with two min restson ice. The sonicated cells
were centrifuged at 48,000 x g for 30 min in a Beckman TL100
ultracentrifuge, and the supernatantwas collected, the protein
concentration of which was determined by measuring the A280
using the following equation that corrects for thepresence of
nucleic acids: Protein concentration (mg /ml) =(1.55x A280)-(0.76 x
A260) (Harlow and Lane, 1988). Glycerolwas added to a final
concentration of 10%, Triton X-100 was added to 1%, and theextract
was diluted with BB buffer so the final protein concentrationwas 15
mg/ml. This E. coli extract was stored until neededat -80°C, at
which time it was thawed, diluted to 3 mg/ml with BB buffer
containing 10% glycerol and 1% Triton X-100. Theextract was
centrifuged 175,000 x g for 30 min and thesupernatant, containing
0.2 mM phenylmethylsulfonyl fluoride (PMSF),was used in the
interaction assays.
Turnip leaf extract was made by grinding two turnip leaves
with a mortar and pestle in 1 ml of BB buffer. Theturnip leaves
were then transferred to microfuge tubes and centrifuged at 16,000
x g for 15 min. The supernatant was transferred to a new tube and
the protein concentration was determinedas described above.
Glycerol and Triton X-100 were added to 10% and 1% respectively,
the extract was diluted to 7 mg/ml andwas stored at -80°C until
needed. Prior to use in an interactionassay, the extract was
centrifuged at 175,000 x g for 30 min and PMSFwas added to a
concentration of 0.2 mM.64
5.2.4Interaction assay
Forty ill of the GST fusion glutathione-agarose slurry were
added to 200 ii.1 of the above E. call extract and mixed well. In vitro
translations of selected transcripts were performed as described in
the Methods section of Chapter 2. Between 4 and 6µl of the
translation reaction (5,000-20,000 cpm for p7052 translations and
150,000 cpm for the TYMC translations) were combined with 200
R1 of E. coli extract, incubated on ice for 15 min and then centrifuged
16,000 x g for 15 min. The supernatant was combined with the GST-
fusion beads-E. coli extract mix and then rotated at 4°C for 1-3
hours. The beads were washed three times with BB buffer
containing 10% glycerol and 1% Triton X-100 (Swaffield and
Johnston, 1996). Ten t1,12X LB (31 mM Tris, pH 6.8, 4% SDS, 20%
sucrose, 0.01% bromphenol blue, 10% f- mercaptoethanol) were
added, the tubes were boiled for 5 min, and then centrifuged for 1
min at 16,000 x g. The proteins were separated by 0.1% SDS/10%
PAGE, and exposed to film for 2-5 days.
5.3Results and Discussion
5.3.1Expression of GST fusion proteins
The construct pGEX-hel (Fig. 5.2), directed the production ofa
GST -TYMV helicase fusion protein that, along with a few
degradation products, were bound by the glutathione-agarose (Fig.
5.3, lane 4). The helicase fusion migrated at an apparent molecular
weight of about 65 kDa, close to the expected molecular weight of
67 kDa. The fusions were also detectable by immunoblotting with
either anti-GST (Sigma) or anti-C141 (Fig. 3.1) antibodies (data not
shown).65
A similar clone to pGEX-hel has recently been described that
directs the synthesis of a GST-TYMV helicase fusion in the
expression vector pGEX-2T (Kadare et al., 1996). This fusion protein
purified from E. coli, has demonstrated ATPase, GTPase and RNA
binding activities. The fusion encoded by pGEX-hel differs from the
one described by Kadare et al. only by the addition of 22 amino
acids on the amino terminal side of the helicase domain.
The other three pGEX constructs in Figure 5.2 were capable of
directing synthesis of the GST-ORF-206 protein fusions, but notto
high enough levels to be of use in GST fusion interaction
experiments. Induced DH5a cultures transformed with pGEX-141or
pGEX-141-XF both produced GST-p141 fusions thatwere detectable
by immunoblotting with anti-N-206 (Fig. 3.1) antibodies, indicating
that at least the methyltransferase domain of the p141 insertwas
expressed (data not shown). The protein band pattern producedwas
very similar for both clones, although no full length fusions were
detected, and the induced proteins were not present in Coomassie
blue stainable amounts. pGEX-66 was capable of directing the
synthesis of full length GST-polymerase fusions (data not shown),
but again, the amounts were too low for theiruse in GST fusion
interaction assays.
There are a number of problems thatcan complicate the
overexpression of proteins in E. coll. Overexpression of proteinscan
lead to the formation of inclusion bodies which render the proteins
insoluble (Makrides, 1996). Inclusion bodies, whichare associated
with high levels of protein expression, did notseem to be the
obstacle with the three unsuccessful clones in this study since they
directed only low levels of fusion synthesis. Toxicity of the proteins
encoded by the inserts can also be a problem in the overexpression
of proteins in E. coli (Makrides, 1996) but this did notseem to be a
problem with the TYmv inserts as the growth of the cultures before
and after induction with IPTG was not noticeably different from
that of pGEX-Sal transformants.MTh
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Figure 5.2. Diagrams and predicted molecular weights of the
fusion proteins produced by pGEX-Sal and the other constructs used
in this study. pGEX-Sal encodes a fusion protein that includes the
first 18 amino acids of the TEV polyprotein. The fusion protein
encoded by pGEX-66 includes amino acids 1257 to 1844 of p206
(the entire p66). The fusion protein encoded by pGEX-hel includes
amino acids 894 to 1259 of p206. The conserved helicase-like
domain spans amino acids 960-1198 of p206. The pGEX-141-XF
construct encodes a fusion that includes amino acids 1-1061 of
p206, and pGEX-141 encodes a fusion protein that includes amino
acids 1-1259 of p206, the entire p141. All of these constructs create
fusion proteins consisting of GST, a TEV NIa proteinase cleavage site,
and the insert protein.67
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Figure 5-3. Purified GST-fusion proteins. Lanes 1 and 3 of this
Coomassie blue-stained 0.1% SDS/10% PAGE represent the total
soluble proteins of IPTG-induced cultures of E. coli strain DH5a
transformed with either pGEX-Sal (lane 1) or pGEX-hel (lane 3).
Lanes 2 and 4 represent the proteins purified with 40 IA ofa 50%
slurry of glutathione-agarose from the pGEX-Sal and pGEX-hel
transformed cultures, respectively. The expected molecular weight
for the GST-TEV polypeptide fusion is 29 kDa and that for the GST-
TYMV helicase fusion is 67 kDa.
The fusion protein band patterns directed by pGEX-66, pGEX-
141 and pGEX-141-XF contained numerous bands, most of which
corresponded to proteins with smaller molecular weights than those
predicted for the fusions (data not shown). Itwas apparent that
fusion protein synthesis was incomplete and/or the fusionswere
being degraded. Any degradation in this case would not have been
caused by sonication, as these cells were added directly to Laemmli
buffer and boiled for 5 min. One possiblereason for the incomplete
and low levels of fusion protein expression is that the TYMV inserts
contain codons that are unusual in E. coli. The codons AGG, AGA and
CCC are rare in E. coli (Zhang et al., 1991) but are found throughout68
the TYMV genome (Morch et al., 1988; Dreher and Bransom, 1992).
The codon CCC is especially common in the TYMV genome,
occasionally occurring in pairs and triplets, which can be
problematic if the corresponding tRNA is in short supply. It has
been found that low levels of the [ArgHRNAAGA/AGG (encoded by
the argU gene) in Ecoli can hamper the production of certain
recombinant proteins (Brinkmann et al., 1989). Supplying the argU
gene on a high copy number plasmid has been shown to help with
the expression of some recombinant proteins. The plasmid pUBS520
(Brinkmann et al., 1989) contains a argU gene and a kanamycin
resistance gene. The Ecoli strain DH5a transformed with pUBS520
together with one of the pGEX-TYMV insert clones did not result in
higher levels of fusion expression or in the production of longer
fusions (data not shown).
Degradation of the fusion protein, either before or after
sonication, could also be a problem in the production of the GST
fusions. Two protease deficient strains of E. coli were transformed
with pGEX-66 to see if this could improve the yields of the full
length GST-TYMV polymerase fusion. Neither BL21 (Pharmacia),
which is OmpT minus (OmpT encodes an outer membrane-localized
protease), or SF110 (Baneyx and Georgiou, 1990), which is OmpT
minus and DegP minus (DegP encodes a periplasmic protease),
improved the yield of the full length fusion over the yield in DH5a
(data not shown).
Similar new clones to those proposed in Chapter 4 that would
express smaller regions of p141 (e.g. methyltransferase-like
domain, protease domain) as fusions with GST are planned for the
future and will hopefully allow for higher level expression of full
length fusions. Vectors that direct the synthesis of GST fusions in
yeast may also be used.69
5.3.2Results of interaction assays and conclusions
The relatively high yield of the GST-TYMV helicase fusion
from DH5a transformed with pGEX-hel allowed for the use of the
fusion in interaction assays. In vitro translated proteins labeled
with [35S]methionine were added to the agarose-bound fusions, but
in no case were the labeled proteins able to specifically bind to the
fusions. Translation products from two different transcripts were
added to the agarose-bound fusions. In the first case, TYMC full
length genomic transcripts were used and it is possible that the p66
and p141 proteins produced associated with one another in cis so
that the p66 was not available to interact with the agarose-bound
helicase fusion. The second transcript used was transcribed from
p6652 (constructed by Kay Bransom), and translation of this
transcript results in the synthesis of only p66, the TYMV
polymerase. The p66 from the p6652 translation was unable to
interact with the GST-helicase fusion.
A possible reason for the failure of the polymerase and
helicase domains of TYMV to interact in these experiments is that
the proposed interaction between the polymerase and helicase is
mediated by a host protein or TYMV RNA. It has been shown that
the polymerase-like and helicase proteins of BMV interact (Kao et
al., 1992, O'Reilly et al., 1995) and that template RNA is required for
the assembly of BMV replication complexes in yeast (Quadt et al.,
1995). However, the use of turnip extract instead of E. coli extract
for the competitor proteins in the interaction assay, and the
addition of TYMV RNA did not result in the retention of p66 on the
glutathione-agarose (data not shown).
Although there are reasons why the GST fusion interaction
assays may not detect some interactions, the result obtained in this
study are in agreement with the yeast two-hybrid studies that
indicate the helicase domain of p141 does not interact with p66.
Since two different types of experiments could not detect an
interaction between p66 and the helicase domain of p141, future
plans will focus on regions of p141 outside of the helicase domain70
and their potential interaction with p66. It is hoped that the clones
planned for the expression of smaller regions of p141as GST fusions
will be capable of directing the synthesis of high levels of the
fusions and that interaction assays with the p66S2 translations will
help determine where and if p66 and p141 interact.71
6. Discussion
6.1Summary of Results
The purpose of this study was to obtain evidence for the
direct interaction between p141 and p66, two proteins encoded by
ORF-206 of TYMV RNA. Evidence for a direct protein-protein
interaction would support the model, described in Chapter 1 and
illustrated in Fig. 1.3, that explains the cis-preferential replication of
TYMV RNA in turnip protoplasts (Weiland and Dreher, 1993). Three
types of experiments were used to study the postulated interaction
between p141 and p66: Immunoprecipitation of in vitro translated
TYMV proteins, yeast two-hybrid experiments using fusions of ORF-
206 proteins to Gal4 DNA binding and activation domains, and GST
fusion interaction assays where the ability of in vitro translated
TYMV proteins to interact with GST-ORF-206 fusions was
determined.
The immunoprecipitations using C-206 antibodies were able
to precipitate all three of the ORF-206 proteins: p206, p141 and p66
(Fig. 3.2). Since p141 does not contain the C-206 epitope (Fig. 3.1),
p141 was presumed to be coprecipitated by its interaction with
p206 and/or p66, both of which contain the C-206 epitope (Fig. 3.1).
The immunoprecipitations using the other two available antisera
were unable to show coprecipitation of p66 (Fig. 3.2), and possible
reasons for this are discussed in Chapter 3. The use of nested in-
frame deletion mutants suggests that a region in the C-terminal half
of p66 could be involved in an interaction with p141. However,
accurate estimation of p141/p66 ratios was hampered by a
background of p141 recovery.
The yeast two-hybrid experiments have affordeda limited
study of the proposed interactions, since it was only possible to
verify the production of fusion proteins containing the polymerase-
and helicase-like domains of p206. Western analysis using72
monoclonal HA antibodies revealed that some of the larger fusions
did not accumulate to detectable levels (Fig. 4.4), so their
involvement in a protein-protein interaction cannot be ruled out.
Conclusions can be drawn from the results of the yeast
transformant combination of the Ga14 activation domain fusion with
the TYMV polymerase-like protein (pACTII-66) and the Ga14 DNA
binding domain fusion with the TYMV helicase domain (pAS1-hel,
Fig. 4.2) as both of these constructs directed the synthesis of
detectable amounts of the full length fusions (Fig. 4.4). Since the
brome mosaic virus (BMV) proteins containing helicase-like and
polymerase-like domains had been shown to form a complex in
vitro (Kao et al, 1992) and in vivo (O'Reilly et al, 1995), an
interaction between the helicase- and polymerase-like domains of
TYMV seemed plausible. However, the pACTII-66/pAS1-hel
transformant combination did not activate reporter genes in two
different yeast strains, indicating that the helicase- and
polymerase-like domains of TYMV do not detectably interact in this
system.
The GST fusion interaction assays met with limitedsuccess as
most of the GST-ORF-206 protein fusions did not accumulate to high
enough levels in E. coli to permit their use in interactionassays. One
construct, pGEX-hel (Fig. 5.2), was capable of directing the synthesis
of high amounts of GST-TYMV helicase fusions thatwere readily
purified on glutathione-agarose (Fig. 5.3). In vitro translated p66
was added to the agarose-bound helicase fusions but in no case was
p66 able to bind to the fusions, even when turnip extract and TYMV
RNA were added.
The immunoprecipitation results support the model for cis-
preferential replication by providing some indication ofan
interaction between the ORF-206 proteins. However, attempts to
verify this interaction using other methodswere unsuccessful. The
helicase domain of p141 and the polymerase-like protein (p66) do
not interact in a manner that is detectable in either the yeast two-
hybrid assays or the GST fusion interaction assays described in this
study. It is likely that the helicase domain of p141 is not involved73
in the proposed protein-protein interaction between p141 and p66.
No conclusions can be drawn about the involvement of the other
domains of p141, and future experiments will focus on determining
their roles in the proposed interaction with p66.
6.2Possible Modifications to the Model
It is possible that the interaction between the ORF-206
proteins is not direct and that some host protein or host structure is
required for the proposed interaction. p66 and p141 are assumed to
be associated with the TYMV replication complex, and it is
conceivable that p206 is also involved. Analogous proteins to p66
and p141 in BMV (Quadt and Jaspars, 1990), cucumber mosaic virus
(Hayes and Buck, 1990) and poliovirus (Bienz et al., 1990) have
been shown to be part of the viral replication complexes. It is
possible that a deletion in p66 of TYMV could result in the loss of
the ability of p66 to be assembled into a replication complex by
inhibiting its ability to interact with a host protein or the RNA
template, not necessarily by inhibiting a direct interaction with
p141. Wild type p66, supplied in trans, could then form a functional
replication complex with p141. This slight modification to the model
could help explain the ability of genomes containing deletions in the
p66 coding region, to coreplicate in turnip protoplasts (Weiland and
Dreher, 1993) without the requirement for p66 and p141 to interact
directly.
Another factor that could affect the coreplication in turnip
protoplast of certain mutant genomes is the possible requirement
for an active helicase in cis. In this variation (Fig. 6.1) of the model,
the helicase is required to unwind the secondary RNA structure at
the 3' end of the genome either to allow for proper replication
complex assembly or in order for the polymerase (p66) to bind the
promoter. In the case of the helicase point mutant (GCGST) or a
Ahelicase (A2995-3705) genome, the helicase is defective or74
nonfunctional so the 3' end of the genome is not unwound,
replication complexes are not formed or the polymerase cannot bind
the promoter, and the polymerase is free to go in trans (Fig. 6.1B
and 6.1C). It has been shown that the helicase point mutation
(GCGST) resulted in a decrease in the ATPase, GTPase and RNA
binding activity (Kadare et al., 1996), so it is likely that this mutant
would result in reduced template unwinding activity. The Ahelicase
genome, which is missing the helicase coding region and would not
be expected to have any template unwinding activity, behaves in a
similar manner to the GCGST genome in coreplication experiments.
In the case of the polymerase point mutant (RDD), the helicase
produced is functional and can unwind the 3' end of the genome,
allowing replication complexes to form (Fig. 6.1B). If the defective
polymerase can still bind the promoter, it would block the binding
of wild type p66 provided in trans. Whether in a complex or not,
the polymerase is defective, so no replication occurs, assuming there
is only limited displacement by an active polymerase supplied in
trans.
The involvement of an active helicase is consistent with the
ability of the genome with a large deletion in the p66 coding region
(ASP-G, Fig. 1.2) to be complemented by the GCGST and Ahelicase
genomes if the large deletion in p66 results in a protein incapable of
incorporation into a replication complex, or is unable to bind the
promoter. In either case, wild type p66 provided in trans from the
GCGST genome could allow replication of the ASP-G genome (Fig.
6.1C). If wild type p141 encoded by the ASP-G genome is also
available in trans, replication of the GCGST genome would also occur.B
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Figure 6.1. Effects of the helicase function on the cis-
preferential replication of TYMV. (A) Wild type replication
complexes are formed and have a high affinity for their template.
(B) The helicase produced by the GCGST genome is defective and
cannot unwind the 3' end of the genome; the p66 cannot bind its
template so it is available in trans. The RDD genome directs the
assembly of nonfunctional replication complexes, unable to
incorporate wild type p66. (C) The p66 encoded by the ASP-G
genome is not able to be incorporated into replication complexes.
The wild type p66 provided in trans from the GCGSTgenome is then
able to form active replication complexes with wild type p141 from
the ASP-G genome. (D) The helicase produced by the A1536-1759
genome is functional, the 3' end of the genome is unwound and p66
is able to bind the template. Since the supply of p66 from the
A1536-1759 genome is limited, there is little complementation with
the ASP-G genome.76
The model that includes the function of the helicase domain
can account for the results of some of the coreplication experiments
with the defective genomes in Figure 1.2 that could not be
explained solely by the proposed protein-protein interaction
between p141 and p66. The defective genomes A213-1759 and
A1536-1759 (Fig. 1.2) do not allow for the complementation of AS P-
G genomes. These defective genomes should still be able to
complement the replication of ASP-G because, like the GCGST
genome, they encode wild type p66. However, the relative
coreplication rate for A213-1759 and ASP-G was <0.1% and for
A1536-1759 and ASP-G was 3% (Fig. 1.2), indicating poor
complementation. These defective genomes could be translated in
vitro, and the deletions were not found to affect proteolytic
processing (Weiland and Dreher, 1993).
The lack of complementation between ASP-G and the defective
genomes A213-1759 and A1536-1759 can be explained because
both A213-1759 and A1536-1759 encode for wild type helicase
domains. According to the model, as long as the helicase is
functional, the 3' end of the genome will be unwound, and p66 will
be of limited availability in trans (Fig. 6.1D). Onlygenomes that
encode for defective helicase domains (GCGST, Ahelicase) will be
able to provide p66 efficiently in trans. A213-1759 has the entire
methyltransferase-like domain deleted, and the deletion in A1536-
1759 corresponds to 75 amino acids in a region between the
methyltransferase-like domain and the protease domain, but both
genomes encode wild type helicase domains.
The successful complementation of ASP-Ggenomes with ACP
or wild type genomes (data not shown) indicates that having a
nonfunctional helicase is not the only factor that allows for
coreplication. Complementation by wild type and ACPgenomes
could occur in two ways: p66 could be provided intrans as a free
subunit, or p66 could be supplied in trans as part ofa functional
replication complex. If the p66 from the ACP and wild typegenomes
was available in trans as a functional replication complex, not as77
free p66, these results would still be consistent with the affects of a
functional versus nonfunctional helicase. It is possible that only
when the genome encodes for a nonfunctional helicase that does not
allow complex formation, as with GCGST or the Ahelicase genome,
can p66 be provided in trans without being part of a complex with
p141.
6.3Unanswered Questions
A number of details about the cis-preferential replication of
TYMV remain unclear. Future experiments will hopefully help
determine whether p141 and p66 interact directly, whether their
interaction is mediated by a host factor or RNA element, or whether
there is another explanation for the coupling of replication and
translation in TYMV. It will be interesting to determine whether the
complementation of ASP-G genomes by ACP and wild type genomes
occurs by the trans availability of p66 alone or by the availability of
p66 as part of a functional replication complex. It is assumed that
p141 and p66 are both part of the replication complex, but it is
unknown what host proteins may also be associated or whether
uncleaved p206 may be involved. Autocatalytic cleavage of p206 to
p141 and p66 is never complete in vitro (Bransom et al., 1991), but
there is no experimental evidence about the role of p206 in vivo. It
is also unknown how the switch occurs in replication from negative
to positive strand synthesis. It is likely that more than one form of
TYMV replication complexes exist; one form with a preference for
the synthesis of negative strands, one form with a preference for
the synthesis of positive strands, and possibly a third for for the
synthesis of subgenomic RNA. These different forms may involve
variations in the interactions between subunits.78
6.4Future Plans
To answer the question of whether p141 and p66 interact and
whether the interaction is direct, new clones have been designed to
express the methyltransferase-like domain, the protease domain
and the region between the two conserved domains as fusions with
either the Ga14 domains or glutathione S-transferase. These
constructs will hopefully allow for the expression of domains of
p141 that were previously difficult to express as large fusion
proteins. The use of these clones in yeast two-hybrid screens and in
GST fusion interaction assays will hopefully provide information on
the proposed interaction between p141 and p66.
In vivo immunoprecipitations from labeled turnip protoplasts
infected with TYMV are also planned. Replication complexes will be
pre-formed in vivo and as long as the C-206 epitope is not buried in
the complex, immunoprecipitations with C-206 antibodies should
precipitate the complete replication complexes. These experiments
will hopefully show that p141 and p66 form a complex in vivo,
confirming the results of the in vitro immunoprecipitations
described in Chapter 3, and indicate if other proteins are also part
of the complex. If the labeling of viral proteins is not high enough in
the protoplasts to allow for successful immunoprecipitations,
immunoprecipitations of a purified and active TYMV replicase
preparation may be tried instead. Besides demonstrating that p141
and p66 form a complex, these experiments could eventually help
to determine if certain replication complexes have a preference for
negative versus positive strand synthesis and what factors affect
the preference. It is possible that a host protein is associated with
one replication complex form and not in the other, as is the case
with Qp (Blumenthal and Carmichael, 1979), or that an RNA element
is required for the assembly of one form, as has been suggested for
BMV (Duggal et al., 1994). Proteolytic processing of the replication
proteins could presumably allow for conformational changes in the
replication complexes. This type of processing has been shown to be79
responsible for the switch in the template preference for Sindbis
virus (Lemm et al., 1994).
It is hoped that it will eventually be possible to assemble
TYMV replication complexes in yeast, as has been done with BMV
(Quadt et aL, 1995). This will allow for the identification of possible
cis elements that may be required for complex assembly,as was
found with BMV (Quadt et al., 1995), and for the identification of
deletions and point mutations in the genome that preventor inhibit
complex assembly. It will be interesting to see whether the helicase
point mutation (GCGST) or the Ahelicase construct prevent complex
assembly, and support the idea that a defective helicase could allow
p66 to be free to diffuse away from its template.
More coreplication experiments in turnip protoplasts are
planned to further investigate the effects of the helicase GCGST
mutant. The construction of a new mutant genome is planned that
would contain the helicase GCGST mutation and the upstream
deletion of nucleotides 1536-1759. Coreplication with thisnew
mutant genome and the ASP-G genome would be expected to be
similar to the rates for ASP-G + GCGST genome (49%, see Fig.1.2) if
the inactive helicase is what allows for the polymerase to be
available in trans. If the coreplication rates were lower,as with the
A1536-1759 + ASP-G combination (3%, Fig. 1.2), then it would
appear that the A1536-1759 mutation has some dominant effect,
and the importance of a functional helicase in the coupling of
translation and replication of TYMV would not be supported.
Another coreplication experiment that is planned will
hopefully determine whether p66, when translated froma ACP or
wild type genome, is available in trans as part ofa functional
replication complex or is available in trans uncomplexed with p141.
If the replication of a ASP-G genome also containinga GCGST point
mutation can be successfully rescued by a ACP or wild typegenome,
it will be clear that both p66 and p141 are provided in trans (since
p66 and p141 encoded by the ASP-G/GCGSTgenome are both
nonfunctional), possibly in a complexed form. If the ASP-G/GCGST
cannot be complemented by ACP or wild type genomes, then it will80
appear that in this case p141 cannot be provided in trans, and that
p66 is available in trans in an uncomplexed form.
The use of transgenic plants and cauliflower mosaic virus 35S
plasmids were used with alfalfa mosaic virus to show that RNA1
and RNA2 have to be translated, even when the proteins they
encode were provided in trans, to allow for their replication (van
Rossum, et al., 1996). These types of experiments with TYMV will
hopefully be possible in the future and will allow the testing of how
cis-preferential replication is affected if the replication proteins are
provided in trans and in excess.
6.5Summary of Conclusions and Recommendations for
Future Work
The immunoprecipitation data provided some evidence that
p141 forms a complex with p66 and/or p206 in vitro. Since yeast
two-hybrid and GST fusion interaction assays show that the
proposed interaction between p141 and p66 does not involve the
helicase domain of p141, future experiments will focus on
determining the possible involvement of other regions of p141 in an
interaction with p66.81
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